Project
averaged GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for SIN3A_CHD1
Z-value: 2.02
Motif logo
Transcription factors associated with SIN3A_CHD1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
SIN3A
|
ENSG00000169375.11 | SIN3 transcription regulator family member A |
|
CHD1
|
ENSG00000153922.6 | chromodomain helicase DNA binding protein 1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| CHD1 | hg19_v2_chr5_-_98262240_98262240 | 0.30 | 5.7e-06 | Click! |
| SIN3A | hg19_v2_chr15_-_75743991_75744011 | 0.20 | 2.4e-03 | Click! |
Activity profile of SIN3A_CHD1 motif
Sorted Z-values of SIN3A_CHD1 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr7_-_140178775 | 28.70 |
ENST00000474576.1
ENST00000473444.1 ENST00000471104.1 |
MKRN1
|
makorin ring finger protein 1 |
| chr13_-_77900814 | 23.91 |
ENST00000544440.2
|
MYCBP2
|
MYC binding protein 2, E3 ubiquitin protein ligase |
| chr2_+_87140935 | 23.68 |
ENST00000398193.3
|
RGPD1
|
RANBP2-like and GRIP domain containing 1 |
| chr3_-_18466787 | 23.03 |
ENST00000338745.6
ENST00000450898.1 |
SATB1
|
SATB homeobox 1 |
| chr13_-_77901177 | 22.16 |
ENST00000407578.2
ENST00000357337.6 ENST00000360084.5 |
MYCBP2
|
MYC binding protein 2, E3 ubiquitin protein ligase |
| chr17_+_36861735 | 20.74 |
ENST00000378137.5
ENST00000325718.7 |
MLLT6
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6 |
| chr11_-_46142948 | 19.48 |
ENST00000257821.4
|
PHF21A
|
PHD finger protein 21A |
| chr16_-_58231782 | 19.45 |
ENST00000565188.1
ENST00000262506.3 |
CSNK2A2
|
casein kinase 2, alpha prime polypeptide |
| chr8_+_56014949 | 18.48 |
ENST00000327381.6
|
XKR4
|
XK, Kell blood group complex subunit-related family, member 4 |
| chr20_+_57466629 | 18.30 |
ENST00000371081.1
ENST00000338783.6 |
GNAS
|
GNAS complex locus |
| chr10_+_28821674 | 18.28 |
ENST00000526722.1
ENST00000375646.1 |
WAC
|
WW domain containing adaptor with coiled-coil |
| chr10_+_28822236 | 15.74 |
ENST00000347934.4
ENST00000354911.4 |
WAC
|
WW domain containing adaptor with coiled-coil |
| chr14_+_102228123 | 15.26 |
ENST00000422945.2
ENST00000554442.1 ENST00000556260.2 ENST00000328724.5 ENST00000557268.1 |
PPP2R5C
|
protein phosphatase 2, regulatory subunit B', gamma |
| chr9_-_92112953 | 14.54 |
ENST00000339861.4
ENST00000422704.2 ENST00000455551.2 |
SEMA4D
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
| chr15_-_45480153 | 14.50 |
ENST00000560471.1
ENST00000560540.1 |
SHF
|
Src homology 2 domain containing F |
| chr19_+_1285890 | 14.50 |
ENST00000344663.3
|
MUM1
|
melanoma associated antigen (mutated) 1 |
| chr17_+_7788104 | 14.26 |
ENST00000380358.4
|
CHD3
|
chromodomain helicase DNA binding protein 3 |
| chr2_+_203499901 | 13.70 |
ENST00000303116.6
ENST00000392238.2 |
FAM117B
|
family with sequence similarity 117, member B |
| chr16_+_23847267 | 13.65 |
ENST00000321728.7
|
PRKCB
|
protein kinase C, beta |
| chr8_-_101322132 | 13.09 |
ENST00000523481.1
|
RNF19A
|
ring finger protein 19A, RBR E3 ubiquitin protein ligase |
| chr6_-_99797522 | 12.48 |
ENST00000389677.5
|
FAXC
|
failed axon connections homolog (Drosophila) |
| chr19_-_49576198 | 12.37 |
ENST00000221444.1
|
KCNA7
|
potassium voltage-gated channel, shaker-related subfamily, member 7 |
| chr2_-_174828892 | 12.25 |
ENST00000418194.2
|
SP3
|
Sp3 transcription factor |
| chr1_-_53793725 | 12.09 |
ENST00000371454.2
|
LRP8
|
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor |
| chr2_-_61697862 | 11.97 |
ENST00000398571.2
|
USP34
|
ubiquitin specific peptidase 34 |
| chr6_+_139456226 | 11.69 |
ENST00000367658.2
|
HECA
|
headcase homolog (Drosophila) |
| chr3_+_14989186 | 11.56 |
ENST00000435454.1
ENST00000323373.6 |
NR2C2
|
nuclear receptor subfamily 2, group C, member 2 |
| chr16_+_23847339 | 11.45 |
ENST00000303531.7
|
PRKCB
|
protein kinase C, beta |
| chr6_-_13711773 | 11.17 |
ENST00000011619.3
|
RANBP9
|
RAN binding protein 9 |
| chr3_+_157823609 | 11.05 |
ENST00000480820.1
|
RSRC1
|
arginine/serine-rich coiled-coil 1 |
| chr1_+_211432593 | 10.98 |
ENST00000367006.4
|
RCOR3
|
REST corepressor 3 |
| chr7_-_139876812 | 10.78 |
ENST00000397560.2
|
JHDM1D
|
lysine (K)-specific demethylase 7A |
| chr15_-_48470558 | 10.59 |
ENST00000324324.7
|
MYEF2
|
myelin expression factor 2 |
| chr1_-_151431647 | 10.52 |
ENST00000368863.2
ENST00000409503.1 ENST00000491586.1 ENST00000533351.1 ENST00000540984.1 |
POGZ
|
pogo transposable element with ZNF domain |
| chr13_+_114567131 | 10.51 |
ENST00000608651.1
|
GAS6-AS2
|
GAS6 antisense RNA 2 (head to head) |
| chr7_+_148395733 | 10.39 |
ENST00000602748.1
|
CUL1
|
cullin 1 |
| chr11_-_46142615 | 10.29 |
ENST00000529734.1
ENST00000323180.6 |
PHF21A
|
PHD finger protein 21A |
| chr6_-_29600832 | 10.21 |
ENST00000377016.4
ENST00000376977.3 ENST00000377034.4 |
GABBR1
|
gamma-aminobutyric acid (GABA) B receptor, 1 |
| chr17_+_65821780 | 10.17 |
ENST00000321892.4
ENST00000335221.5 ENST00000306378.6 |
BPTF
|
bromodomain PHD finger transcription factor |
| chr2_-_88125286 | 9.97 |
ENST00000327544.6
|
RGPD2
|
RANBP2-like and GRIP domain containing 2 |
| chr6_-_79787902 | 9.70 |
ENST00000275034.4
|
PHIP
|
pleckstrin homology domain interacting protein |
| chr1_-_200992827 | 9.58 |
ENST00000332129.2
ENST00000422435.2 |
KIF21B
|
kinesin family member 21B |
| chr14_+_71374433 | 9.49 |
ENST00000439984.3
|
PCNX
|
pecanex homolog (Drosophila) |
| chr14_+_60715928 | 9.29 |
ENST00000395076.4
|
PPM1A
|
protein phosphatase, Mg2+/Mn2+ dependent, 1A |
| chr2_-_48132814 | 9.18 |
ENST00000316377.4
ENST00000378314.3 |
FBXO11
|
F-box protein 11 |
| chr13_-_31039375 | 9.17 |
ENST00000399494.1
|
HMGB1
|
high mobility group box 1 |
| chr1_-_21503337 | 9.07 |
ENST00000400422.1
ENST00000602326.1 ENST00000411888.1 ENST00000438975.1 |
EIF4G3
|
eukaryotic translation initiation factor 4 gamma, 3 |
| chr16_+_29817841 | 9.06 |
ENST00000322945.6
ENST00000562337.1 ENST00000566906.2 ENST00000563402.1 ENST00000219782.6 |
MAZ
|
MYC-associated zinc finger protein (purine-binding transcription factor) |
| chr14_+_103058948 | 8.91 |
ENST00000262241.6
|
RCOR1
|
REST corepressor 1 |
| chr1_+_211433275 | 8.77 |
ENST00000367005.4
|
RCOR3
|
REST corepressor 3 |
| chr22_-_50221160 | 8.76 |
ENST00000404760.1
|
BRD1
|
bromodomain containing 1 |
| chr8_+_57124245 | 8.59 |
ENST00000521831.1
ENST00000355315.3 ENST00000303759.3 ENST00000517636.1 ENST00000517933.1 ENST00000518801.1 ENST00000523975.1 ENST00000396723.5 ENST00000523061.1 ENST00000521524.1 |
CHCHD7
|
coiled-coil-helix-coiled-coil-helix domain containing 7 |
| chr5_-_176981417 | 8.56 |
ENST00000514747.1
ENST00000443375.2 ENST00000329540.5 |
FAM193B
|
family with sequence similarity 193, member B |
| chr2_-_48132924 | 8.50 |
ENST00000403359.3
|
FBXO11
|
F-box protein 11 |
| chr2_+_86668464 | 8.48 |
ENST00000409064.1
|
KDM3A
|
lysine (K)-specific demethylase 3A |
| chr6_-_89827720 | 8.47 |
ENST00000452027.2
|
SRSF12
|
serine/arginine-rich splicing factor 12 |
| chr19_+_42817527 | 8.45 |
ENST00000598766.1
|
TMEM145
|
transmembrane protein 145 |
| chr17_-_61777090 | 8.43 |
ENST00000578061.1
|
LIMD2
|
LIM domain containing 2 |
| chr17_+_65821636 | 8.40 |
ENST00000544778.2
|
BPTF
|
bromodomain PHD finger transcription factor |
| chr7_-_105029329 | 8.40 |
ENST00000393651.3
ENST00000460391.1 |
SRPK2
|
SRSF protein kinase 2 |
| chr16_+_68119247 | 8.39 |
ENST00000575270.1
|
NFATC3
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 |
| chr11_-_64512469 | 8.39 |
ENST00000377485.1
|
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
| chr7_+_138145145 | 8.13 |
ENST00000415680.2
|
TRIM24
|
tripartite motif containing 24 |
| chr3_+_155588375 | 8.07 |
ENST00000295920.7
|
GMPS
|
guanine monphosphate synthase |
| chr4_-_102268484 | 8.04 |
ENST00000394853.4
|
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme |
| chr1_+_118148556 | 8.00 |
ENST00000369448.3
|
FAM46C
|
family with sequence similarity 46, member C |
| chr5_+_49963239 | 7.99 |
ENST00000505554.1
|
PARP8
|
poly (ADP-ribose) polymerase family, member 8 |
| chr9_-_132805430 | 7.86 |
ENST00000446176.2
ENST00000355681.3 ENST00000420781.1 |
FNBP1
|
formin binding protein 1 |
| chr17_-_61777459 | 7.86 |
ENST00000578993.1
ENST00000583211.1 ENST00000259006.3 |
LIMD2
|
LIM domain containing 2 |
| chr1_+_174128639 | 7.84 |
ENST00000251507.4
|
RABGAP1L
|
RAB GTPase activating protein 1-like |
| chr5_-_81046841 | 7.79 |
ENST00000509013.2
ENST00000505980.1 ENST00000509053.1 |
SSBP2
|
single-stranded DNA binding protein 2 |
| chrX_+_23352133 | 7.78 |
ENST00000379361.4
|
PTCHD1
|
patched domain containing 1 |
| chr19_-_55866104 | 7.69 |
ENST00000326529.4
|
COX6B2
|
cytochrome c oxidase subunit VIb polypeptide 2 (testis) |
| chr2_-_38604398 | 7.68 |
ENST00000443098.1
ENST00000449130.1 ENST00000378954.4 ENST00000539122.1 ENST00000419554.2 ENST00000451483.1 ENST00000406122.1 |
ATL2
|
atlastin GTPase 2 |
| chr17_-_42276574 | 7.66 |
ENST00000589805.1
|
ATXN7L3
|
ataxin 7-like 3 |
| chr19_+_14800711 | 7.63 |
ENST00000536363.1
ENST00000540689.2 ENST00000601134.1 ENST00000292530.6 |
ZNF333
|
zinc finger protein 333 |
| chr15_+_92396920 | 7.63 |
ENST00000318445.6
|
SLCO3A1
|
solute carrier organic anion transporter family, member 3A1 |
| chr6_-_111804393 | 7.60 |
ENST00000368802.3
ENST00000368805.1 |
REV3L
|
REV3-like, polymerase (DNA directed), zeta, catalytic subunit |
| chr14_+_105886150 | 7.59 |
ENST00000331320.7
ENST00000406191.1 |
MTA1
|
metastasis associated 1 |
| chr11_+_67033881 | 7.49 |
ENST00000308595.5
ENST00000526285.1 |
ADRBK1
|
adrenergic, beta, receptor kinase 1 |
| chr14_+_105886275 | 7.42 |
ENST00000405646.1
|
MTA1
|
metastasis associated 1 |
| chr1_+_84543734 | 7.38 |
ENST00000370689.2
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta |
| chr12_+_66218598 | 7.34 |
ENST00000541363.1
|
HMGA2
|
high mobility group AT-hook 2 |
| chrX_+_131157322 | 7.32 |
ENST00000481105.1
ENST00000354719.6 ENST00000394335.2 |
MST4
|
Serine/threonine-protein kinase MST4 |
| chrX_+_131157290 | 7.30 |
ENST00000394334.2
|
MST4
|
Serine/threonine-protein kinase MST4 |
| chr1_+_151254738 | 7.27 |
ENST00000336715.6
ENST00000324048.5 ENST00000368879.2 |
ZNF687
|
zinc finger protein 687 |
| chr12_+_122241928 | 7.26 |
ENST00000604567.1
ENST00000542440.1 |
SETD1B
|
SET domain containing 1B |
| chr6_-_17706618 | 7.26 |
ENST00000262077.2
ENST00000537253.1 |
NUP153
|
nucleoporin 153kDa |
| chr16_-_89007491 | 7.25 |
ENST00000327483.5
ENST00000564416.1 |
CBFA2T3
|
core-binding factor, runt domain, alpha subunit 2; translocated to, 3 |
| chr13_+_20532900 | 7.20 |
ENST00000382871.2
|
ZMYM2
|
zinc finger, MYM-type 2 |
| chr20_-_35492048 | 7.14 |
ENST00000237536.4
|
SOGA1
|
suppressor of glucose, autophagy associated 1 |
| chr17_+_33895090 | 7.11 |
ENST00000592381.1
|
RP11-1094M14.11
|
RP11-1094M14.11 |
| chr1_-_53018654 | 7.09 |
ENST00000257177.4
ENST00000355809.4 ENST00000528642.1 ENST00000470626.1 ENST00000371544.3 |
ZCCHC11
|
zinc finger, CCHC domain containing 11 |
| chr7_+_29874341 | 7.08 |
ENST00000409290.1
ENST00000242140.5 |
WIPF3
|
WAS/WASL interacting protein family, member 3 |
| chr8_-_54935001 | 7.06 |
ENST00000396401.3
ENST00000521604.2 |
TCEA1
|
transcription elongation factor A (SII), 1 |
| chr5_-_81046904 | 7.03 |
ENST00000515395.1
|
SSBP2
|
single-stranded DNA binding protein 2 |
| chr2_+_234263120 | 7.03 |
ENST00000264057.2
ENST00000427930.1 |
DGKD
|
diacylglycerol kinase, delta 130kDa |
| chr4_-_102268628 | 6.91 |
ENST00000323055.6
ENST00000512215.1 ENST00000394854.3 |
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme |
| chr1_-_25256368 | 6.88 |
ENST00000308873.6
|
RUNX3
|
runt-related transcription factor 3 |
| chr14_-_99737565 | 6.85 |
ENST00000357195.3
|
BCL11B
|
B-cell CLL/lymphoma 11B (zinc finger protein) |
| chr8_-_125486755 | 6.80 |
ENST00000499418.2
ENST00000530778.1 |
RNF139-AS1
|
RNF139 antisense RNA 1 (head to head) |
| chr8_+_61591337 | 6.79 |
ENST00000423902.2
|
CHD7
|
chromodomain helicase DNA binding protein 7 |
| chr12_-_25403737 | 6.77 |
ENST00000256078.4
ENST00000556131.1 ENST00000311936.3 ENST00000557334.1 |
KRAS
|
Kirsten rat sarcoma viral oncogene homolog |
| chr11_-_76091986 | 6.75 |
ENST00000260045.3
|
PRKRIR
|
protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) |
| chr10_+_22610124 | 6.74 |
ENST00000376663.3
|
BMI1
|
BMI1 polycomb ring finger oncogene |
| chr6_-_170124027 | 6.68 |
ENST00000366780.4
ENST00000339209.4 |
PHF10
|
PHD finger protein 10 |
| chr9_+_128509663 | 6.66 |
ENST00000373489.5
ENST00000373483.2 |
PBX3
|
pre-B-cell leukemia homeobox 3 |
| chr13_-_30881621 | 6.59 |
ENST00000380615.3
|
KATNAL1
|
katanin p60 subunit A-like 1 |
| chr17_+_30469473 | 6.58 |
ENST00000333942.6
ENST00000358365.3 ENST00000583994.1 ENST00000545287.2 |
RHOT1
|
ras homolog family member T1 |
| chr13_+_20532848 | 6.57 |
ENST00000382874.2
|
ZMYM2
|
zinc finger, MYM-type 2 |
| chr18_-_48723690 | 6.57 |
ENST00000406189.3
|
MEX3C
|
mex-3 RNA binding family member C |
| chr6_+_20403997 | 6.56 |
ENST00000535432.1
|
E2F3
|
E2F transcription factor 3 |
| chr8_-_103424986 | 6.53 |
ENST00000521922.1
|
UBR5
|
ubiquitin protein ligase E3 component n-recognin 5 |
| chr16_+_28943260 | 6.51 |
ENST00000538922.1
ENST00000324662.3 ENST00000567541.1 |
CD19
|
CD19 molecule |
| chr18_-_29522989 | 6.50 |
ENST00000582539.1
ENST00000283351.4 ENST00000582513.1 |
TRAPPC8
|
trafficking protein particle complex 8 |
| chr2_+_169312725 | 6.50 |
ENST00000392687.4
|
CERS6
|
ceramide synthase 6 |
| chr17_+_43299241 | 6.50 |
ENST00000328118.3
|
FMNL1
|
formin-like 1 |
| chr12_-_42631529 | 6.49 |
ENST00000548917.1
|
YAF2
|
YY1 associated factor 2 |
| chr10_+_112679301 | 6.46 |
ENST00000265277.5
ENST00000369452.4 |
SHOC2
|
soc-2 suppressor of clear homolog (C. elegans) |
| chr8_-_57123815 | 6.40 |
ENST00000316981.3
ENST00000423799.2 ENST00000429357.2 |
PLAG1
|
pleiomorphic adenoma gene 1 |
| chr20_-_62711259 | 6.40 |
ENST00000332298.5
|
RGS19
|
regulator of G-protein signaling 19 |
| chr20_+_55926274 | 6.39 |
ENST00000371242.2
ENST00000527947.1 |
RAE1
|
ribonucleic acid export 1 |
| chr15_-_65810042 | 6.37 |
ENST00000321147.6
|
DPP8
|
dipeptidyl-peptidase 8 |
| chr7_-_140179276 | 6.35 |
ENST00000443720.2
ENST00000255977.2 |
MKRN1
|
makorin ring finger protein 1 |
| chr5_+_6714718 | 6.34 |
ENST00000230859.6
ENST00000515721.1 |
PAPD7
|
PAP associated domain containing 7 |
| chr2_-_230786619 | 6.31 |
ENST00000389045.3
ENST00000409677.1 |
TRIP12
|
thyroid hormone receptor interactor 12 |
| chr19_-_47975417 | 6.30 |
ENST00000236877.6
|
SLC8A2
|
solute carrier family 8 (sodium/calcium exchanger), member 2 |
| chr12_-_76478386 | 6.30 |
ENST00000535020.2
|
NAP1L1
|
nucleosome assembly protein 1-like 1 |
| chr14_+_57857262 | 6.29 |
ENST00000555166.1
ENST00000556492.1 ENST00000554703.1 |
NAA30
|
N(alpha)-acetyltransferase 30, NatC catalytic subunit |
| chr17_-_47841485 | 6.26 |
ENST00000506156.1
ENST00000240364.2 |
FAM117A
|
family with sequence similarity 117, member A |
| chr16_+_87636474 | 6.23 |
ENST00000284262.2
|
JPH3
|
junctophilin 3 |
| chr16_+_12995468 | 6.12 |
ENST00000424107.3
ENST00000558583.1 ENST00000558318.1 |
SHISA9
|
shisa family member 9 |
| chr11_-_64512803 | 6.12 |
ENST00000377489.1
ENST00000354024.3 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
| chr16_+_29817399 | 6.11 |
ENST00000545521.1
|
MAZ
|
MYC-associated zinc finger protein (purine-binding transcription factor) |
| chr1_-_161168834 | 6.10 |
ENST00000367995.3
ENST00000367996.5 |
ADAMTS4
|
ADAM metallopeptidase with thrombospondin type 1 motif, 4 |
| chr7_+_65338230 | 6.10 |
ENST00000360768.3
|
VKORC1L1
|
vitamin K epoxide reductase complex, subunit 1-like 1 |
| chr6_+_161412759 | 6.09 |
ENST00000366919.2
ENST00000392142.4 ENST00000366920.2 ENST00000348824.7 |
MAP3K4
|
mitogen-activated protein kinase kinase kinase 4 |
| chr6_+_33378738 | 6.08 |
ENST00000374512.3
ENST00000374516.3 |
PHF1
|
PHD finger protein 1 |
| chr6_-_31864977 | 6.06 |
ENST00000395728.3
ENST00000375528.4 |
EHMT2
|
euchromatic histone-lysine N-methyltransferase 2 |
| chr17_+_30264014 | 6.05 |
ENST00000322652.5
ENST00000580398.1 |
SUZ12
|
SUZ12 polycomb repressive complex 2 subunit |
| chr3_+_197476621 | 6.02 |
ENST00000241502.4
|
FYTTD1
|
forty-two-three domain containing 1 |
| chr1_-_179846928 | 6.02 |
ENST00000367612.3
ENST00000609928.1 |
TOR1AIP2
|
torsin A interacting protein 2 |
| chr7_-_105029812 | 5.97 |
ENST00000482897.1
|
SRPK2
|
SRSF protein kinase 2 |
| chr8_-_103424916 | 5.96 |
ENST00000220959.4
|
UBR5
|
ubiquitin protein ligase E3 component n-recognin 5 |
| chr10_-_103578162 | 5.96 |
ENST00000361464.3
ENST00000357797.5 ENST00000370094.3 |
MGEA5
|
meningioma expressed antigen 5 (hyaluronidase) |
| chr13_-_44361025 | 5.96 |
ENST00000261488.6
|
ENOX1
|
ecto-NOX disulfide-thiol exchanger 1 |
| chr21_+_17102311 | 5.95 |
ENST00000285679.6
ENST00000351097.5 ENST00000285681.2 ENST00000400183.2 |
USP25
|
ubiquitin specific peptidase 25 |
| chr13_-_52027134 | 5.94 |
ENST00000311234.4
ENST00000425000.1 ENST00000463928.1 ENST00000442263.3 ENST00000398119.2 |
INTS6
|
integrator complex subunit 6 |
| chr2_+_105471969 | 5.90 |
ENST00000361360.2
|
POU3F3
|
POU class 3 homeobox 3 |
| chr20_-_4804244 | 5.90 |
ENST00000379400.3
|
RASSF2
|
Ras association (RalGDS/AF-6) domain family member 2 |
| chr8_-_67525473 | 5.88 |
ENST00000522677.3
|
MYBL1
|
v-myb avian myeloblastosis viral oncogene homolog-like 1 |
| chr3_+_141121164 | 5.88 |
ENST00000510338.1
ENST00000504673.1 |
ZBTB38
|
zinc finger and BTB domain containing 38 |
| chr17_-_60142609 | 5.88 |
ENST00000397786.2
|
MED13
|
mediator complex subunit 13 |
| chr3_-_33481835 | 5.83 |
ENST00000283629.3
|
UBP1
|
upstream binding protein 1 (LBP-1a) |
| chr8_-_133493200 | 5.81 |
ENST00000388996.4
|
KCNQ3
|
potassium voltage-gated channel, KQT-like subfamily, member 3 |
| chr14_+_100594914 | 5.78 |
ENST00000554695.1
|
EVL
|
Enah/Vasp-like |
| chr10_+_93683519 | 5.77 |
ENST00000265990.6
|
BTAF1
|
BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, 170kDa |
| chr9_+_131218698 | 5.76 |
ENST00000434106.3
ENST00000546203.1 ENST00000446274.1 ENST00000421776.2 ENST00000432065.2 |
ODF2
|
outer dense fiber of sperm tails 2 |
| chr10_+_28822636 | 5.76 |
ENST00000442148.1
ENST00000448193.1 |
WAC
|
WW domain containing adaptor with coiled-coil |
| chr10_-_88281494 | 5.71 |
ENST00000298767.5
|
WAPAL
|
wings apart-like homolog (Drosophila) |
| chr21_-_10990888 | 5.71 |
ENST00000298232.7
|
TPTE
|
transmembrane phosphatase with tensin homology |
| chrX_-_70329118 | 5.71 |
ENST00000374188.3
|
IL2RG
|
interleukin 2 receptor, gamma |
| chr4_+_3076388 | 5.69 |
ENST00000355072.5
|
HTT
|
huntingtin |
| chr3_-_56717246 | 5.69 |
ENST00000355628.5
|
FAM208A
|
family with sequence similarity 208, member A |
| chr9_-_88356789 | 5.66 |
ENST00000357081.3
ENST00000376081.4 ENST00000337006.4 ENST00000376109.3 |
AGTPBP1
|
ATP/GTP binding protein 1 |
| chr7_-_140178726 | 5.59 |
ENST00000480552.1
|
MKRN1
|
makorin ring finger protein 1 |
| chr1_+_93811438 | 5.58 |
ENST00000370272.4
ENST00000370267.1 |
DR1
|
down-regulator of transcription 1, TBP-binding (negative cofactor 2) |
| chr7_-_148581251 | 5.57 |
ENST00000478654.1
ENST00000460911.1 ENST00000350995.2 |
EZH2
|
enhancer of zeste homolog 2 (Drosophila) |
| chr1_-_54872059 | 5.56 |
ENST00000371320.3
|
SSBP3
|
single stranded DNA binding protein 3 |
| chr16_+_53164833 | 5.56 |
ENST00000564845.1
|
CHD9
|
chromodomain helicase DNA binding protein 9 |
| chr3_-_18466026 | 5.55 |
ENST00000417717.2
|
SATB1
|
SATB homeobox 1 |
| chr17_+_30469579 | 5.54 |
ENST00000354266.3
ENST00000581094.1 ENST00000394692.2 |
RHOT1
|
ras homolog family member T1 |
| chr21_-_10990830 | 5.54 |
ENST00000361285.4
ENST00000342420.5 ENST00000328758.5 |
TPTE
|
transmembrane phosphatase with tensin homology |
| chr2_-_54197915 | 5.53 |
ENST00000404125.1
|
PSME4
|
proteasome (prosome, macropain) activator subunit 4 |
| chr17_+_38278826 | 5.52 |
ENST00000577454.1
ENST00000578648.1 ENST00000579565.1 |
MSL1
|
male-specific lethal 1 homolog (Drosophila) |
| chr2_-_172017343 | 5.51 |
ENST00000431350.2
ENST00000360843.3 |
TLK1
|
tousled-like kinase 1 |
| chr16_+_50187556 | 5.51 |
ENST00000561678.1
ENST00000357464.3 |
PAPD5
|
PAP associated domain containing 5 |
| chr5_-_88178964 | 5.49 |
ENST00000513252.1
ENST00000508569.1 ENST00000510942.1 ENST00000506554.1 |
MEF2C
|
myocyte enhancer factor 2C |
| chr7_+_35840819 | 5.49 |
ENST00000399035.3
|
SEPT7
|
septin 7 |
| chr17_-_38721711 | 5.48 |
ENST00000578085.1
ENST00000246657.2 |
CCR7
|
chemokine (C-C motif) receptor 7 |
| chr11_+_63706444 | 5.48 |
ENST00000377793.4
ENST00000456907.2 ENST00000539656.1 |
NAA40
|
N(alpha)-acetyltransferase 40, NatD catalytic subunit |
| chr5_-_88179302 | 5.47 |
ENST00000504921.2
|
MEF2C
|
myocyte enhancer factor 2C |
| chr19_+_54466179 | 5.46 |
ENST00000270458.2
|
CACNG8
|
calcium channel, voltage-dependent, gamma subunit 8 |
| chr18_-_44497308 | 5.46 |
ENST00000585916.1
ENST00000324794.7 ENST00000545673.1 |
PIAS2
|
protein inhibitor of activated STAT, 2 |
| chr15_-_61521495 | 5.45 |
ENST00000335670.6
|
RORA
|
RAR-related orphan receptor A |
| chr6_-_43337180 | 5.45 |
ENST00000318149.3
ENST00000361428.2 |
ZNF318
|
zinc finger protein 318 |
| chr4_+_154387480 | 5.44 |
ENST00000409663.3
ENST00000440693.1 ENST00000409959.3 |
KIAA0922
|
KIAA0922 |
| chr17_+_79373540 | 5.42 |
ENST00000307745.7
|
RP11-1055B8.7
|
BAH and coiled-coil domain-containing protein 1 |
| chr17_-_36413133 | 5.41 |
ENST00000523089.1
ENST00000312412.4 ENST00000520237.1 |
RP11-1407O15.2
|
TBC1 domain family member 3 |
| chr3_+_180630444 | 5.40 |
ENST00000491062.1
ENST00000468861.1 ENST00000445140.2 ENST00000484958.1 |
FXR1
|
fragile X mental retardation, autosomal homolog 1 |
| chr7_-_148581360 | 5.39 |
ENST00000320356.2
ENST00000541220.1 ENST00000483967.1 ENST00000536783.1 |
EZH2
|
enhancer of zeste homolog 2 (Drosophila) |
| chr14_+_75230011 | 5.38 |
ENST00000552421.1
ENST00000325680.7 ENST00000238571.3 |
YLPM1
|
YLP motif containing 1 |
| chr15_-_65809991 | 5.37 |
ENST00000559526.1
ENST00000358939.4 ENST00000560665.1 ENST00000321118.7 ENST00000339244.5 ENST00000300141.6 |
DPP8
|
dipeptidyl-peptidase 8 |
| chr10_+_69644404 | 5.37 |
ENST00000212015.6
|
SIRT1
|
sirtuin 1 |
| chr8_-_131028660 | 5.36 |
ENST00000401979.2
ENST00000517654.1 ENST00000522361.1 ENST00000518167.1 |
FAM49B
|
family with sequence similarity 49, member B |
| chr9_+_128509624 | 5.35 |
ENST00000342287.5
ENST00000373487.4 |
PBX3
|
pre-B-cell leukemia homeobox 3 |
| chr15_-_38856836 | 5.35 |
ENST00000450598.2
ENST00000559830.1 ENST00000558164.1 ENST00000310803.5 |
RASGRP1
|
RAS guanyl releasing protein 1 (calcium and DAG-regulated) |
| chr10_-_103578182 | 5.35 |
ENST00000439817.1
|
MGEA5
|
meningioma expressed antigen 5 (hyaluronidase) |
| chr22_+_31031639 | 5.33 |
ENST00000343605.4
ENST00000300385.8 |
SLC35E4
|
solute carrier family 35, member E4 |
| chr17_-_74236382 | 5.32 |
ENST00000592271.1
ENST00000319945.6 ENST00000269391.6 |
RNF157
|
ring finger protein 157 |
Network of associatons between targets according to the STRING database.
First level regulatory network of SIN3A_CHD1
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 11.2 | 44.9 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 8.8 | 26.3 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
| 6.0 | 18.0 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
| 5.5 | 5.5 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 5.0 | 15.0 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
| 4.8 | 14.5 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
| 3.7 | 14.9 | GO:0003138 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
| 3.7 | 11.0 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 3.7 | 11.0 | GO:0036333 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 3.7 | 18.3 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 3.6 | 25.5 | GO:1901315 | negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
| 3.6 | 10.8 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 3.4 | 10.1 | GO:0060844 | arterial endothelial cell fate commitment(GO:0060844) blood vessel lumenization(GO:0072554) positive regulation of ephrin receptor signaling pathway(GO:1901189) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
| 3.4 | 13.4 | GO:0002840 | plasmacytoid dendritic cell activation(GO:0002270) T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) regulation of restriction endodeoxyribonuclease activity(GO:0032072) negative regulation of apoptotic cell clearance(GO:2000426) |
| 3.3 | 10.0 | GO:1904800 | negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 2.9 | 20.4 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
| 2.9 | 8.7 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
| 2.9 | 8.6 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
| 2.9 | 8.6 | GO:0070902 | mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
| 2.8 | 8.5 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
| 2.8 | 16.8 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 2.8 | 11.2 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
| 2.8 | 8.3 | GO:0019056 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 2.8 | 11.0 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 2.7 | 8.0 | GO:0031052 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) positive regulation of cellular response to X-ray(GO:2000685) |
| 2.5 | 40.2 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 2.5 | 5.0 | GO:2001038 | regulation of cellular response to drug(GO:2001038) |
| 2.4 | 14.6 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
| 2.3 | 13.9 | GO:2000568 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
| 2.3 | 2.3 | GO:0034250 | positive regulation of cellular amide metabolic process(GO:0034250) |
| 2.3 | 13.7 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 2.3 | 9.1 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 2.2 | 8.6 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 2.1 | 14.6 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
| 2.1 | 12.4 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 2.0 | 10.2 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
| 2.0 | 4.0 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
| 2.0 | 8.0 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
| 2.0 | 10.0 | GO:0097338 | response to clozapine(GO:0097338) |
| 2.0 | 4.0 | GO:2000683 | regulation of cellular response to X-ray(GO:2000683) |
| 2.0 | 3.9 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
| 1.9 | 5.7 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
| 1.9 | 7.6 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
| 1.9 | 11.4 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
| 1.9 | 15.1 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 1.9 | 7.5 | GO:0021897 | forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) |
| 1.9 | 5.6 | GO:0046098 | guanine metabolic process(GO:0046098) |
| 1.9 | 13.1 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 1.8 | 9.1 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 1.8 | 9.1 | GO:2000638 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
| 1.8 | 5.4 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 1.8 | 7.2 | GO:0033206 | meiotic cytokinesis(GO:0033206) |
| 1.8 | 5.4 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 1.7 | 5.2 | GO:2000681 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 1.7 | 5.1 | GO:1904247 | positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 1.7 | 8.5 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
| 1.7 | 8.5 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 1.7 | 15.2 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
| 1.7 | 3.4 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
| 1.7 | 1.7 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
| 1.7 | 6.7 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 1.7 | 5.0 | GO:1990922 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 1.7 | 9.9 | GO:0032252 | secretory granule localization(GO:0032252) |
| 1.6 | 6.5 | GO:0030242 | pexophagy(GO:0030242) |
| 1.6 | 9.7 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 1.6 | 6.4 | GO:0007538 | primary sex determination(GO:0007538) |
| 1.6 | 6.4 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
| 1.6 | 8.0 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 1.6 | 1.6 | GO:0046541 | saliva secretion(GO:0046541) |
| 1.6 | 14.3 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 1.6 | 6.2 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 1.6 | 6.2 | GO:0015966 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 1.6 | 45.1 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
| 1.5 | 7.7 | GO:0010587 | miRNA catabolic process(GO:0010587) |
| 1.5 | 9.2 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
| 1.5 | 13.8 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 1.5 | 16.7 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 1.5 | 4.5 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
| 1.5 | 4.5 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
| 1.5 | 19.3 | GO:0051382 | kinetochore assembly(GO:0051382) |
| 1.5 | 8.9 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 1.5 | 2.9 | GO:2000569 | T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
| 1.5 | 1.5 | GO:1904397 | negative regulation of neuromuscular junction development(GO:1904397) |
| 1.5 | 7.3 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
| 1.4 | 17.4 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 1.4 | 14.4 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 1.4 | 1.4 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 1.4 | 8.5 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 1.4 | 5.7 | GO:0007070 | negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
| 1.4 | 7.1 | GO:0071895 | odontoblast differentiation(GO:0071895) |
| 1.4 | 11.3 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 1.4 | 8.4 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 1.4 | 7.0 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
| 1.4 | 4.2 | GO:0019827 | stem cell population maintenance(GO:0019827) |
| 1.4 | 8.2 | GO:0051013 | microtubule severing(GO:0051013) |
| 1.3 | 5.3 | GO:0097368 | histone H4-K20 trimethylation(GO:0034773) establishment of Sertoli cell barrier(GO:0097368) |
| 1.3 | 4.0 | GO:0050894 | determination of affect(GO:0050894) |
| 1.3 | 3.9 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
| 1.3 | 3.9 | GO:0009447 | putrescine catabolic process(GO:0009447) |
| 1.3 | 11.7 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
| 1.3 | 8.9 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
| 1.3 | 3.8 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
| 1.3 | 1.3 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 1.3 | 13.9 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 1.3 | 8.8 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
| 1.3 | 5.0 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
| 1.2 | 7.4 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
| 1.2 | 3.7 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 1.2 | 7.3 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 1.2 | 3.6 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
| 1.2 | 2.4 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
| 1.2 | 2.4 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 1.2 | 19.2 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
| 1.2 | 5.9 | GO:0072069 | DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
| 1.2 | 3.5 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
| 1.2 | 5.8 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
| 1.1 | 1.1 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 1.1 | 11.3 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
| 1.1 | 7.9 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
| 1.1 | 15.7 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
| 1.1 | 15.6 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 1.1 | 4.5 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 1.1 | 4.4 | GO:0019086 | late viral transcription(GO:0019086) |
| 1.1 | 23.3 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
| 1.1 | 2.2 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
| 1.1 | 4.4 | GO:0009386 | translational attenuation(GO:0009386) |
| 1.1 | 5.5 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 1.1 | 3.3 | GO:0033385 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 1.1 | 1.1 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 1.1 | 11.7 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
| 1.1 | 2.1 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
| 1.1 | 8.5 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 1.1 | 3.2 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 1.1 | 5.3 | GO:0080009 | mRNA methylation(GO:0080009) |
| 1.0 | 3.1 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
| 1.0 | 3.1 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
| 1.0 | 11.2 | GO:0034465 | response to carbon monoxide(GO:0034465) |
| 1.0 | 2.0 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
| 1.0 | 31.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 1.0 | 3.0 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 1.0 | 2.0 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 1.0 | 6.9 | GO:0043634 | polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
| 1.0 | 3.9 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 1.0 | 4.9 | GO:1990034 | calcium ion export from cell(GO:1990034) |
| 1.0 | 4.9 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
| 1.0 | 1.0 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
| 1.0 | 6.7 | GO:0098704 | fructose transport(GO:0015755) fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
| 1.0 | 1.0 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
| 1.0 | 4.8 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 1.0 | 3.8 | GO:0002326 | B cell lineage commitment(GO:0002326) |
| 0.9 | 1.9 | GO:1990737 | response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
| 0.9 | 5.6 | GO:0071321 | cellular response to cGMP(GO:0071321) |
| 0.9 | 9.1 | GO:0019695 | choline metabolic process(GO:0019695) |
| 0.9 | 1.8 | GO:0001866 | NK T cell proliferation(GO:0001866) |
| 0.9 | 6.4 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
| 0.9 | 11.7 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
| 0.9 | 7.2 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.9 | 6.2 | GO:0035624 | receptor transactivation(GO:0035624) |
| 0.9 | 2.6 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
| 0.9 | 1.8 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
| 0.9 | 4.4 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
| 0.9 | 6.1 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.9 | 2.6 | GO:0021937 | ventral midline development(GO:0007418) cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
| 0.9 | 1.7 | GO:0014040 | positive regulation of Schwann cell differentiation(GO:0014040) |
| 0.9 | 2.6 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
| 0.9 | 1.7 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
| 0.9 | 12.8 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.9 | 2.6 | GO:0006864 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 0.8 | 1.7 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.8 | 9.3 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
| 0.8 | 5.9 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.8 | 1.7 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
| 0.8 | 2.5 | GO:0036058 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
| 0.8 | 16.5 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.8 | 24.8 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.8 | 2.5 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 0.8 | 5.0 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.8 | 0.8 | GO:0021860 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
| 0.8 | 9.0 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.8 | 3.3 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 0.8 | 2.5 | GO:0048104 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 0.8 | 2.5 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.8 | 1.6 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
| 0.8 | 11.4 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
| 0.8 | 3.2 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
| 0.8 | 2.4 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.8 | 13.7 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
| 0.8 | 2.4 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
| 0.8 | 4.0 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 0.8 | 3.2 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
| 0.8 | 3.2 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.8 | 3.1 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 0.8 | 0.8 | GO:1903525 | regulation of membrane tubulation(GO:1903525) positive regulation of membrane tubulation(GO:1903527) |
| 0.8 | 4.7 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
| 0.8 | 3.9 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) positive regulation of autophagosome maturation(GO:1901098) |
| 0.8 | 2.3 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
| 0.8 | 1.5 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
| 0.8 | 6.8 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
| 0.8 | 2.3 | GO:0032648 | interferon-beta production(GO:0032608) regulation of interferon-beta production(GO:0032648) |
| 0.8 | 0.8 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 0.8 | 31.6 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.8 | 2.3 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 0.8 | 20.3 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 0.8 | 12.8 | GO:0006337 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) |
| 0.7 | 0.7 | GO:0002661 | B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
| 0.7 | 3.7 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
| 0.7 | 4.4 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
| 0.7 | 9.5 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.7 | 0.7 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.7 | 2.2 | GO:0044771 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.7 | 1.5 | GO:0043615 | astrocyte cell migration(GO:0043615) |
| 0.7 | 0.7 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
| 0.7 | 1.4 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) negative regulation of ERAD pathway(GO:1904293) |
| 0.7 | 1.4 | GO:0072040 | regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072039) negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072040) mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:1901145) negative regulation of somatic stem cell population maintenance(GO:1904673) |
| 0.7 | 4.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.7 | 6.4 | GO:0002371 | dendritic cell cytokine production(GO:0002371) |
| 0.7 | 9.9 | GO:0072520 | seminiferous tubule development(GO:0072520) |
| 0.7 | 2.1 | GO:0030101 | natural killer cell activation(GO:0030101) |
| 0.7 | 1.4 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 0.7 | 2.1 | GO:0016926 | protein desumoylation(GO:0016926) |
| 0.7 | 2.1 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.7 | 2.8 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.7 | 0.7 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 0.7 | 2.1 | GO:0019417 | sulfur oxidation(GO:0019417) |
| 0.7 | 0.7 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 0.7 | 5.5 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.7 | 8.9 | GO:0021794 | thalamus development(GO:0021794) |
| 0.7 | 4.1 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
| 0.7 | 4.0 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
| 0.7 | 4.0 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
| 0.7 | 7.4 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.7 | 3.3 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
| 0.7 | 3.3 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.7 | 2.0 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
| 0.7 | 1.3 | GO:1905245 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) regulation of aspartic-type peptidase activity(GO:1905245) |
| 0.7 | 9.1 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 0.6 | 6.5 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.6 | 0.6 | GO:0030104 | water homeostasis(GO:0030104) |
| 0.6 | 1.9 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.6 | 3.2 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
| 0.6 | 0.6 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
| 0.6 | 4.5 | GO:0007379 | segment specification(GO:0007379) |
| 0.6 | 2.5 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 0.6 | 6.3 | GO:1904424 | regulation of GTP binding(GO:1904424) |
| 0.6 | 3.1 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
| 0.6 | 1.9 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.6 | 5.0 | GO:0030578 | PML body organization(GO:0030578) |
| 0.6 | 6.2 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
| 0.6 | 2.5 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
| 0.6 | 3.7 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 0.6 | 4.9 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
| 0.6 | 0.6 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
| 0.6 | 11.0 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.6 | 14.0 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.6 | 1.2 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 0.6 | 1.8 | GO:0044784 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
| 0.6 | 1.8 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
| 0.6 | 6.7 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
| 0.6 | 0.6 | GO:0042446 | hormone biosynthetic process(GO:0042446) |
| 0.6 | 23.5 | GO:0045841 | negative regulation of mitotic metaphase/anaphase transition(GO:0045841) negative regulation of metaphase/anaphase transition of cell cycle(GO:1902100) |
| 0.6 | 2.4 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.6 | 17.4 | GO:0006376 | mRNA splice site selection(GO:0006376) |
| 0.6 | 2.4 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
| 0.6 | 0.6 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
| 0.6 | 3.0 | GO:1904627 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 0.6 | 1.8 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.6 | 1.8 | GO:0061386 | closure of optic fissure(GO:0061386) |
| 0.6 | 10.5 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
| 0.6 | 0.6 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
| 0.6 | 1.7 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
| 0.6 | 15.1 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
| 0.6 | 2.9 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
| 0.6 | 1.7 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
| 0.6 | 2.3 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
| 0.6 | 0.6 | GO:0030225 | macrophage differentiation(GO:0030225) |
| 0.6 | 1.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
| 0.6 | 1.7 | GO:0003343 | proepicardium development(GO:0003342) septum transversum development(GO:0003343) |
| 0.6 | 1.7 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
| 0.6 | 2.2 | GO:0015917 | aminophospholipid transport(GO:0015917) |
| 0.6 | 4.5 | GO:0097107 | postsynaptic density organization(GO:0097106) postsynaptic density assembly(GO:0097107) |
| 0.6 | 0.6 | GO:0048478 | replication fork protection(GO:0048478) |
| 0.6 | 7.8 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
| 0.5 | 14.2 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.5 | 1.1 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
| 0.5 | 1.6 | GO:0032053 | ciliary basal body organization(GO:0032053) |
| 0.5 | 4.9 | GO:0070459 | prolactin secretion(GO:0070459) |
| 0.5 | 0.5 | GO:0072560 | glandular epithelial cell maturation(GO:0002071) type B pancreatic cell maturation(GO:0072560) |
| 0.5 | 2.7 | GO:0022605 | ovarian cumulus expansion(GO:0001550) oogenesis stage(GO:0022605) fused antrum stage(GO:0048165) |
| 0.5 | 7.0 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.5 | 1.1 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
| 0.5 | 2.7 | GO:0070669 | response to interleukin-2(GO:0070669) |
| 0.5 | 2.7 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
| 0.5 | 1.6 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.5 | 3.2 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
| 0.5 | 1.1 | GO:0060025 | regulation of synaptic activity(GO:0060025) |
| 0.5 | 66.4 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
| 0.5 | 2.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
| 0.5 | 2.1 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.5 | 3.1 | GO:0006378 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
| 0.5 | 1.0 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 0.5 | 0.5 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
| 0.5 | 1.6 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) response to methylglyoxal(GO:0051595) regulation of histone H3-K27 acetylation(GO:1901674) |
| 0.5 | 4.6 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.5 | 2.6 | GO:0046601 | positive regulation of centrosome duplication(GO:0010825) positive regulation of centriole replication(GO:0046601) |
| 0.5 | 4.1 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
| 0.5 | 3.1 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
| 0.5 | 2.1 | GO:0072166 | posterior mesonephric tubule development(GO:0072166) negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) negative regulation of female gonad development(GO:2000195) |
| 0.5 | 1.5 | GO:0015870 | acetylcholine transport(GO:0015870) |
| 0.5 | 1.5 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.5 | 4.5 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
| 0.5 | 4.0 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
| 0.5 | 1.0 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.5 | 13.6 | GO:0070076 | histone lysine demethylation(GO:0070076) |
| 0.5 | 4.0 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
| 0.5 | 2.0 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) |
| 0.5 | 2.0 | GO:0021997 | response to chlorate(GO:0010157) neural plate axis specification(GO:0021997) |
| 0.5 | 2.9 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.5 | 1.0 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
| 0.5 | 7.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.5 | 1.9 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
| 0.5 | 1.9 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 0.5 | 4.9 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
| 0.5 | 24.6 | GO:0006338 | chromatin remodeling(GO:0006338) |
| 0.5 | 0.5 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.5 | 5.8 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
| 0.5 | 1.4 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
| 0.5 | 7.7 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
| 0.5 | 9.1 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.5 | 36.8 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
| 0.5 | 1.4 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
| 0.5 | 2.4 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 0.5 | 0.9 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.5 | 7.1 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.5 | 1.9 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 0.5 | 0.9 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
| 0.5 | 4.7 | GO:1900364 | negative regulation of mRNA 3'-end processing(GO:0031441) negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.5 | 3.3 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.5 | 5.1 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 0.5 | 0.9 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.5 | 3.7 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.5 | 1.8 | GO:0061358 | negative regulation of Wnt protein secretion(GO:0061358) |
| 0.5 | 6.9 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.5 | 1.4 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
| 0.5 | 1.4 | GO:1904386 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
| 0.5 | 1.4 | GO:0051086 | chaperone mediated protein folding independent of cofactor(GO:0051086) |
| 0.5 | 1.4 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
| 0.5 | 11.7 | GO:0044458 | motile cilium assembly(GO:0044458) |
| 0.4 | 2.2 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.4 | 0.4 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
| 0.4 | 1.3 | GO:0031126 | snoRNA 3'-end processing(GO:0031126) |
| 0.4 | 0.9 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.4 | 2.7 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.4 | 0.4 | GO:0098917 | retrograde trans-synaptic signaling(GO:0098917) retrograde trans-synaptic signaling by soluble gas(GO:0098923) trans-synaptic signaling by soluble gas(GO:0099543) |
| 0.4 | 1.3 | GO:0043132 | FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) NAD transport(GO:0043132) |
| 0.4 | 7.5 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.4 | 0.4 | GO:0007616 | long-term memory(GO:0007616) |
| 0.4 | 1.3 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
| 0.4 | 1.8 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.4 | 1.8 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
| 0.4 | 1.7 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
| 0.4 | 1.3 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.4 | 2.1 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.4 | 7.2 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.4 | 5.1 | GO:0051195 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.4 | 1.3 | GO:0034471 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 0.4 | 1.7 | GO:0051866 | general adaptation syndrome(GO:0051866) |
| 0.4 | 4.6 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.4 | 1.7 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
| 0.4 | 3.3 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.4 | 0.8 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
| 0.4 | 2.0 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
| 0.4 | 36.4 | GO:0007286 | spermatid development(GO:0007286) |
| 0.4 | 0.4 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 0.4 | 2.4 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
| 0.4 | 2.0 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
| 0.4 | 3.3 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
| 0.4 | 2.8 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.4 | 1.6 | GO:0010998 | regulation of translational initiation by eIF2 alpha phosphorylation(GO:0010998) |
| 0.4 | 4.4 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
| 0.4 | 2.8 | GO:0032456 | endocytic recycling(GO:0032456) |
| 0.4 | 8.4 | GO:2000637 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.4 | 1.2 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.4 | 7.2 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.4 | 8.0 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
| 0.4 | 0.8 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.4 | 2.8 | GO:0021840 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 0.4 | 1.6 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
| 0.4 | 9.1 | GO:0016574 | histone ubiquitination(GO:0016574) |
| 0.4 | 2.7 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.4 | 1.2 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.4 | 1.6 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.4 | 2.7 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.4 | 17.4 | GO:0016575 | histone deacetylation(GO:0016575) |
| 0.4 | 1.5 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 0.4 | 0.8 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 0.4 | 3.8 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
| 0.4 | 4.6 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.4 | 1.1 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
| 0.4 | 0.4 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 0.4 | 0.8 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
| 0.4 | 2.3 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 0.4 | 0.4 | GO:0030194 | positive regulation of blood coagulation(GO:0030194) positive regulation of coagulation(GO:0050820) positive regulation of hemostasis(GO:1900048) |
| 0.4 | 1.1 | GO:0072114 | pronephros morphogenesis(GO:0072114) |
| 0.4 | 0.8 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
| 0.4 | 0.8 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
| 0.4 | 1.1 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.4 | 1.1 | GO:1901355 | response to rapamycin(GO:1901355) |
| 0.4 | 18.6 | GO:0043966 | histone H3 acetylation(GO:0043966) |
| 0.4 | 0.4 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.4 | 10.7 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.4 | 4.4 | GO:0060242 | contact inhibition(GO:0060242) |
| 0.4 | 0.4 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
| 0.4 | 1.1 | GO:0016525 | negative regulation of angiogenesis(GO:0016525) negative regulation of blood vessel morphogenesis(GO:2000181) |
| 0.4 | 10.9 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.4 | 0.4 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 0.4 | 1.1 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 0.4 | 0.7 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) positive regulation of synaptic vesicle clustering(GO:2000809) |
| 0.4 | 2.1 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.4 | 0.7 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
| 0.4 | 3.2 | GO:0032264 | IMP salvage(GO:0032264) |
| 0.4 | 2.5 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.4 | 2.5 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.4 | 8.2 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
| 0.4 | 1.1 | GO:1901143 | insulin catabolic process(GO:1901143) |
| 0.4 | 0.7 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
| 0.4 | 1.4 | GO:1904978 | regulation of endosome organization(GO:1904978) |
| 0.4 | 1.1 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
| 0.4 | 8.1 | GO:0007020 | microtubule nucleation(GO:0007020) |
| 0.4 | 2.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.3 | 2.1 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.3 | 0.3 | GO:2000137 | cell proliferation involved in heart valve morphogenesis(GO:0003249) regulation of cell proliferation involved in heart valve morphogenesis(GO:0003250) negative regulation of cell proliferation involved in heart morphogenesis(GO:2000137) |
| 0.3 | 5.5 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
| 0.3 | 10.7 | GO:0035456 | response to interferon-beta(GO:0035456) |
| 0.3 | 0.7 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.3 | 0.7 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
| 0.3 | 2.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
| 0.3 | 1.4 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.3 | 1.7 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 0.3 | 0.3 | GO:0070673 | response to interleukin-18(GO:0070673) |
| 0.3 | 1.7 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing by siRNA(GO:0090625) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.3 | 3.1 | GO:0034311 | sphingosine metabolic process(GO:0006670) diol metabolic process(GO:0034311) |
| 0.3 | 2.7 | GO:0060872 | semicircular canal development(GO:0060872) |
| 0.3 | 1.0 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.3 | 0.3 | GO:0046666 | retinal cell programmed cell death(GO:0046666) |
| 0.3 | 2.7 | GO:0015074 | DNA integration(GO:0015074) |
| 0.3 | 3.7 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
| 0.3 | 2.3 | GO:0045007 | depurination(GO:0045007) |
| 0.3 | 2.3 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.3 | 2.3 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.3 | 1.9 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 0.3 | 1.0 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.3 | 6.1 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.3 | 0.6 | GO:2001190 | positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
| 0.3 | 0.6 | GO:0060398 | positive regulation of skeletal muscle cell proliferation(GO:0014858) regulation of growth hormone receptor signaling pathway(GO:0060398) positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
| 0.3 | 6.3 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
| 0.3 | 0.9 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.3 | 0.6 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.3 | 0.9 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
| 0.3 | 21.7 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
| 0.3 | 1.3 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.3 | 0.6 | GO:0021586 | pons maturation(GO:0021586) |
| 0.3 | 1.2 | GO:0045357 | interferon-beta biosynthetic process(GO:0045350) regulation of interferon-beta biosynthetic process(GO:0045357) positive regulation of interferon-beta biosynthetic process(GO:0045359) |
| 0.3 | 2.5 | GO:0070314 | G1 to G0 transition(GO:0070314) |
| 0.3 | 2.5 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
| 0.3 | 6.2 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.3 | 2.1 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 0.3 | 0.9 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
| 0.3 | 1.5 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 0.3 | 5.4 | GO:0034453 | microtubule anchoring(GO:0034453) |
| 0.3 | 1.8 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.3 | 0.6 | GO:0048733 | sebaceous gland development(GO:0048733) |
| 0.3 | 1.8 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
| 0.3 | 3.0 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
| 0.3 | 2.4 | GO:1900004 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.3 | 1.5 | GO:0034214 | protein hexamerization(GO:0034214) |
| 0.3 | 0.9 | GO:1903401 | L-lysine transmembrane transport(GO:1903401) |
| 0.3 | 1.5 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.3 | 0.9 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.3 | 1.2 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
| 0.3 | 0.9 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.3 | 0.9 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 0.3 | 0.3 | GO:0043144 | snoRNA processing(GO:0043144) |
| 0.3 | 1.2 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) positive regulation of androgen receptor activity(GO:2000825) |
| 0.3 | 1.4 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 0.3 | 0.6 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.3 | 2.6 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
| 0.3 | 0.3 | GO:0061055 | myotome development(GO:0061055) |
| 0.3 | 1.4 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.3 | 0.9 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.3 | 0.6 | GO:1990089 | response to nerve growth factor(GO:1990089) cellular response to nerve growth factor stimulus(GO:1990090) |
| 0.3 | 2.0 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
| 0.3 | 5.4 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.3 | 6.2 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
| 0.3 | 9.1 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 0.3 | 1.4 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 0.3 | 2.2 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.3 | 0.8 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.3 | 2.5 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.3 | 0.8 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.3 | 9.2 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.3 | 1.4 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
| 0.3 | 1.7 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.3 | 0.8 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.3 | 1.7 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
| 0.3 | 0.6 | GO:0044782 | cilium organization(GO:0044782) |
| 0.3 | 2.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.3 | 0.3 | GO:0005989 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
| 0.3 | 2.7 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.3 | 13.1 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.3 | 1.6 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.3 | 4.3 | GO:0071431 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.3 | 0.5 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.3 | 3.5 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.3 | 0.8 | GO:0046710 | GDP metabolic process(GO:0046710) |
| 0.3 | 2.4 | GO:0042940 | D-amino acid transport(GO:0042940) |
| 0.3 | 1.1 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.3 | 0.8 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
| 0.3 | 0.8 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.3 | 0.8 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.3 | 1.3 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
| 0.3 | 2.4 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.3 | 0.8 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
| 0.3 | 4.0 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.3 | 2.1 | GO:0097484 | dendrite extension(GO:0097484) |
| 0.3 | 1.0 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
| 0.3 | 1.6 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
| 0.3 | 18.8 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
| 0.3 | 0.8 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
| 0.3 | 3.9 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.3 | 4.4 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.3 | 4.7 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
| 0.3 | 0.8 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 0.3 | 2.3 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 0.3 | 0.3 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.3 | 2.6 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.3 | 2.6 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
| 0.3 | 0.8 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.3 | 0.5 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
| 0.3 | 9.7 | GO:0016925 | protein sumoylation(GO:0016925) |
| 0.3 | 66.8 | GO:0000209 | protein polyubiquitination(GO:0000209) |
| 0.3 | 1.3 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
| 0.3 | 0.5 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
| 0.3 | 3.3 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.3 | 1.0 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
| 0.3 | 1.3 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
| 0.2 | 1.0 | GO:0021766 | hippocampus development(GO:0021766) |
| 0.2 | 0.5 | GO:0042635 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
| 0.2 | 5.2 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.2 | 3.5 | GO:0043576 | regulation of respiratory gaseous exchange(GO:0043576) |
| 0.2 | 2.5 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
| 0.2 | 3.2 | GO:0001782 | B cell homeostasis(GO:0001782) |
| 0.2 | 0.2 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
| 0.2 | 1.0 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
| 0.2 | 2.9 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.2 | 0.5 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
| 0.2 | 1.4 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.2 | 0.5 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
| 0.2 | 1.2 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.2 | 0.5 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 0.2 | 3.3 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.2 | 0.7 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
| 0.2 | 1.7 | GO:0000717 | nucleotide-excision repair, DNA duplex unwinding(GO:0000717) |
| 0.2 | 1.9 | GO:0010737 | protein kinase A signaling(GO:0010737) |
| 0.2 | 1.7 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
| 0.2 | 1.4 | GO:0002115 | store-operated calcium entry(GO:0002115) |
| 0.2 | 0.2 | GO:0010586 | miRNA metabolic process(GO:0010586) |
| 0.2 | 1.6 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
| 0.2 | 1.2 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.2 | 3.0 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
| 0.2 | 0.2 | GO:0048333 | mesodermal cell differentiation(GO:0048333) |
| 0.2 | 3.7 | GO:0010165 | response to X-ray(GO:0010165) |
| 0.2 | 3.7 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.2 | 0.7 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.2 | 1.2 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.2 | 0.5 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
| 0.2 | 0.5 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 0.2 | 1.4 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.2 | 21.5 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
| 0.2 | 1.1 | GO:0044088 | regulation of vacuole organization(GO:0044088) regulation of autophagosome assembly(GO:2000785) |
| 0.2 | 2.5 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
| 0.2 | 5.5 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
| 0.2 | 1.1 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 0.2 | 8.8 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.2 | 4.0 | GO:0072662 | protein targeting to peroxisome(GO:0006625) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.2 | 23.2 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
| 0.2 | 0.7 | GO:0060013 | righting reflex(GO:0060013) |
| 0.2 | 2.2 | GO:0014047 | glutamate secretion(GO:0014047) |
| 0.2 | 0.4 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.2 | 0.4 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.2 | 0.9 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.2 | 1.3 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
| 0.2 | 0.4 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) |
| 0.2 | 1.1 | GO:0015862 | uridine transport(GO:0015862) |
| 0.2 | 0.6 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
| 0.2 | 0.6 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
| 0.2 | 0.9 | GO:0023041 | neuronal signal transduction(GO:0023041) |
| 0.2 | 0.2 | GO:0001771 | immunological synapse formation(GO:0001771) |
| 0.2 | 0.9 | GO:0090399 | replicative senescence(GO:0090399) |
| 0.2 | 0.4 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.2 | 0.4 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
| 0.2 | 4.2 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.2 | 5.5 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 0.2 | 0.8 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
| 0.2 | 1.3 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
| 0.2 | 0.2 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
| 0.2 | 2.3 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
| 0.2 | 0.6 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.2 | 1.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.2 | 1.8 | GO:0007569 | cell aging(GO:0007569) |
| 0.2 | 1.2 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
| 0.2 | 0.4 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
| 0.2 | 0.8 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
| 0.2 | 1.0 | GO:0001999 | renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) renin secretion into blood stream(GO:0002001) |
| 0.2 | 2.4 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
| 0.2 | 4.5 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
| 0.2 | 0.2 | GO:0051590 | positive regulation of neurotransmitter transport(GO:0051590) |
| 0.2 | 1.4 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.2 | 0.6 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 0.2 | 0.6 | GO:0032223 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.2 | 0.4 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
| 0.2 | 4.5 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
| 0.2 | 0.6 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
| 0.2 | 0.4 | GO:0099541 | negative regulation of dopamine secretion(GO:0033602) trans-synaptic signaling by lipid(GO:0099541) trans-synaptic signaling by endocannabinoid(GO:0099542) trans-synaptic signalling, modulating synaptic transmission(GO:0099550) trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
| 0.2 | 2.6 | GO:0006397 | mRNA processing(GO:0006397) |
| 0.2 | 0.8 | GO:0021756 | striatum development(GO:0021756) |
| 0.2 | 6.1 | GO:0035036 | sperm-egg recognition(GO:0035036) |
| 0.2 | 1.4 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.2 | 0.8 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
| 0.2 | 1.0 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
| 0.2 | 31.3 | GO:0006325 | chromatin organization(GO:0006325) |
| 0.2 | 0.4 | GO:0031622 | positive regulation of fever generation(GO:0031622) |
| 0.2 | 0.2 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
| 0.2 | 0.8 | GO:0014029 | neural crest formation(GO:0014029) |
| 0.2 | 1.7 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
| 0.2 | 2.7 | GO:0098534 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
| 0.2 | 0.8 | GO:0006740 | NADPH regeneration(GO:0006740) |
| 0.2 | 0.2 | GO:0097466 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
| 0.2 | 2.3 | GO:0032212 | positive regulation of telomere maintenance via telomerase(GO:0032212) |
| 0.2 | 0.2 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.2 | 1.1 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.2 | 0.4 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) DNA endoreduplication(GO:0042023) |
| 0.2 | 0.6 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.2 | 0.2 | GO:0006288 | base-excision repair, DNA ligation(GO:0006288) |
| 0.2 | 0.7 | GO:0042026 | protein refolding(GO:0042026) |
| 0.2 | 0.2 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
| 0.2 | 1.3 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.2 | 2.0 | GO:0043584 | nose development(GO:0043584) |
| 0.2 | 1.1 | GO:0060482 | lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
| 0.2 | 13.9 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
| 0.2 | 0.5 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
| 0.2 | 0.7 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.2 | 0.9 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
| 0.2 | 0.2 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
| 0.2 | 0.4 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
| 0.2 | 0.2 | GO:1900744 | p38MAPK cascade(GO:0038066) regulation of p38MAPK cascade(GO:1900744) positive regulation of p38MAPK cascade(GO:1900745) |
| 0.2 | 2.6 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
| 0.2 | 1.7 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.2 | 2.4 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.2 | 1.2 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
| 0.2 | 0.5 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.2 | 3.7 | GO:0038096 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
| 0.2 | 0.8 | GO:0006561 | proline biosynthetic process(GO:0006561) L-proline biosynthetic process(GO:0055129) |
| 0.2 | 0.7 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.2 | 1.2 | GO:0044266 | angiotensin catabolic process in blood(GO:0002005) multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) |
| 0.2 | 0.7 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
| 0.2 | 0.7 | GO:0098761 | interleukin-7-mediated signaling pathway(GO:0038111) response to interleukin-7(GO:0098760) cellular response to interleukin-7(GO:0098761) |
| 0.2 | 2.3 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.2 | 0.7 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.2 | 0.3 | GO:0003383 | apical constriction(GO:0003383) |
| 0.2 | 0.7 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
| 0.2 | 0.8 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.2 | 0.7 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 0.2 | 0.5 | GO:1901033 | positive regulation of response to reactive oxygen species(GO:1901033) positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
| 0.2 | 0.7 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 0.2 | 1.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.2 | 0.2 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
| 0.2 | 0.7 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.2 | 0.5 | GO:0046080 | dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
| 0.2 | 0.7 | GO:0032225 | regulation of synaptic transmission, dopaminergic(GO:0032225) |
| 0.2 | 1.5 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
| 0.2 | 0.5 | GO:0051934 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 0.2 | 0.8 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.2 | 0.2 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.2 | 1.3 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.2 | 1.0 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
| 0.2 | 1.9 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.2 | 0.6 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.2 | 0.8 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.2 | 0.3 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
| 0.2 | 5.3 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.2 | 6.8 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
| 0.2 | 0.5 | GO:0072710 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
| 0.2 | 0.8 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
| 0.2 | 2.5 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 0.2 | 0.5 | GO:0021591 | ventricular system development(GO:0021591) |
| 0.2 | 2.9 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.2 | 1.7 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.2 | 0.8 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.2 | 4.2 | GO:0000086 | G2/M transition of mitotic cell cycle(GO:0000086) cell cycle G2/M phase transition(GO:0044839) |
| 0.2 | 0.8 | GO:0043308 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
| 0.1 | 0.6 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
| 0.1 | 0.4 | GO:0021763 | subthalamus development(GO:0021539) subthalamic nucleus development(GO:0021763) prolactin secreting cell differentiation(GO:0060127) left lung development(GO:0060459) left lung morphogenesis(GO:0060460) pulmonary vein morphogenesis(GO:0060577) superior vena cava morphogenesis(GO:0060578) |
| 0.1 | 3.9 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
| 0.1 | 1.8 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.1 | 0.6 | GO:2000489 | hepatic stellate cell activation(GO:0035733) regulation of hepatic stellate cell activation(GO:2000489) |
| 0.1 | 3.4 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
| 0.1 | 0.6 | GO:0019348 | dolichol metabolic process(GO:0019348) |
| 0.1 | 0.7 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.1 | 1.5 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.1 | 0.3 | GO:1990403 | embryonic brain development(GO:1990403) |
| 0.1 | 1.7 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 0.1 | 0.1 | GO:2000364 | regulation of STAT protein import into nucleus(GO:2000364) positive regulation of STAT protein import into nucleus(GO:2000366) |
| 0.1 | 1.3 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.1 | 1.1 | GO:0030856 | regulation of epithelial cell differentiation(GO:0030856) |
| 0.1 | 1.3 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.1 | 1.1 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
| 0.1 | 0.3 | GO:0021589 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 0.1 | 1.1 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
| 0.1 | 1.0 | GO:0046040 | IMP metabolic process(GO:0046040) |
| 0.1 | 0.3 | GO:0051182 | coenzyme transport(GO:0051182) |
| 0.1 | 0.1 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
| 0.1 | 0.8 | GO:0052422 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
| 0.1 | 1.5 | GO:0048536 | spleen development(GO:0048536) |
| 0.1 | 0.3 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.1 | 0.8 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.1 | 0.1 | GO:1903764 | regulation of potassium ion export(GO:1902302) regulation of potassium ion export across plasma membrane(GO:1903764) |
| 0.1 | 0.7 | GO:1903236 | regulation of leukocyte tethering or rolling(GO:1903236) |
| 0.1 | 1.6 | GO:0006884 | cell volume homeostasis(GO:0006884) |
| 0.1 | 1.2 | GO:0071539 | protein localization to centrosome(GO:0071539) |
| 0.1 | 0.5 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
| 0.1 | 0.6 | GO:0035799 | ureter maturation(GO:0035799) |
| 0.1 | 3.9 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
| 0.1 | 0.9 | GO:0006772 | thiamine metabolic process(GO:0006772) |
| 0.1 | 0.9 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.1 | 0.4 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 0.1 | 0.9 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
| 0.1 | 1.0 | GO:0021517 | ventral spinal cord development(GO:0021517) |
| 0.1 | 1.5 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.1 | 0.8 | GO:1901160 | primary amino compound metabolic process(GO:1901160) |
| 0.1 | 0.6 | GO:0051036 | regulation of endosome size(GO:0051036) |
| 0.1 | 0.4 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.1 | 0.6 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
| 0.1 | 0.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.1 | 0.3 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.1 | 0.9 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 0.1 | 0.4 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
| 0.1 | 3.5 | GO:0008089 | anterograde axonal transport(GO:0008089) |
| 0.1 | 0.9 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
| 0.1 | 0.4 | GO:0002568 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
| 0.1 | 1.4 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
| 0.1 | 0.2 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
| 0.1 | 0.7 | GO:0048820 | hair follicle maturation(GO:0048820) |
| 0.1 | 2.0 | GO:0060117 | auditory receptor cell development(GO:0060117) |
| 0.1 | 10.5 | GO:0008033 | tRNA processing(GO:0008033) |
| 0.1 | 1.8 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.1 | 0.4 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
| 0.1 | 0.1 | GO:0048541 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) Peyer's patch morphogenesis(GO:0061146) |
| 0.1 | 0.5 | GO:0048243 | norepinephrine secretion(GO:0048243) |
| 0.1 | 0.4 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.1 | 0.6 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.1 | 0.1 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.1 | 0.5 | GO:0060074 | synapse maturation(GO:0060074) |
| 0.1 | 0.7 | GO:0002335 | mature B cell differentiation(GO:0002335) |
| 0.1 | 1.1 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.1 | 0.7 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
| 0.1 | 1.0 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.1 | 0.2 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.1 | 0.5 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
| 0.1 | 2.3 | GO:0008213 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
| 0.1 | 0.6 | GO:0090520 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.1 | 0.3 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
| 0.1 | 2.0 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
| 0.1 | 1.0 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.1 | 0.2 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
| 0.1 | 3.2 | GO:0071824 | protein-DNA complex subunit organization(GO:0071824) |
| 0.1 | 1.1 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
| 0.1 | 1.3 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
| 0.1 | 0.2 | GO:0048793 | pronephros development(GO:0048793) |
| 0.1 | 0.1 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.1 | 1.2 | GO:0006771 | riboflavin metabolic process(GO:0006771) flavin-containing compound metabolic process(GO:0042726) |
| 0.1 | 0.3 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
| 0.1 | 0.4 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) |
| 0.1 | 0.8 | GO:0030238 | male sex determination(GO:0030238) |
| 0.1 | 0.4 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.1 | 0.6 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.1 | 0.5 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 0.1 | 3.1 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
| 0.1 | 1.8 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
| 0.1 | 3.9 | GO:0002223 | stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
| 0.1 | 0.6 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 0.1 | 2.2 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.1 | 0.4 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
| 0.1 | 0.8 | GO:0006089 | lactate metabolic process(GO:0006089) |
| 0.1 | 1.4 | GO:0051194 | positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
| 0.1 | 0.5 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
| 0.1 | 1.6 | GO:0010863 | positive regulation of phospholipase C activity(GO:0010863) regulation of phospholipase C activity(GO:1900274) |
| 0.1 | 2.6 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
| 0.1 | 1.5 | GO:0033280 | response to vitamin D(GO:0033280) |
| 0.1 | 0.8 | GO:0009409 | response to cold(GO:0009409) |
| 0.1 | 1.1 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.1 | 2.2 | GO:0051168 | nuclear export(GO:0051168) |
| 0.1 | 0.9 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
| 0.1 | 0.4 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
| 0.1 | 0.1 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
| 0.1 | 0.5 | GO:0032965 | regulation of collagen biosynthetic process(GO:0032965) |
| 0.1 | 0.5 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.1 | 0.9 | GO:0050706 | regulation of interleukin-1 beta secretion(GO:0050706) |
| 0.1 | 1.4 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.1 | 1.5 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.1 | 0.3 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 0.1 | 0.3 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.1 | 0.5 | GO:0006302 | double-strand break repair(GO:0006302) |
| 0.1 | 5.4 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.1 | 0.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.1 | 0.2 | GO:0050968 | thermoception(GO:0050955) detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 0.1 | 0.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.1 | 0.9 | GO:0030148 | sphingolipid biosynthetic process(GO:0030148) |
| 0.1 | 0.8 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.1 | 1.1 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
| 0.1 | 4.0 | GO:0071349 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
| 0.1 | 0.2 | GO:0007097 | nuclear migration(GO:0007097) |
| 0.1 | 0.3 | GO:0009224 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.1 | 0.2 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
| 0.1 | 1.6 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
| 0.1 | 0.3 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 0.1 | 0.1 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.1 | 0.1 | GO:0035973 | aggrephagy(GO:0035973) |
| 0.1 | 0.4 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.1 | 0.8 | GO:0051444 | negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
| 0.1 | 25.8 | GO:0016567 | protein ubiquitination(GO:0016567) |
| 0.1 | 0.3 | GO:0046349 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) amino sugar biosynthetic process(GO:0046349) |
| 0.1 | 2.0 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
| 0.1 | 0.2 | GO:0001768 | establishment of T cell polarity(GO:0001768) |
| 0.1 | 0.2 | GO:0015791 | polyol transport(GO:0015791) |
| 0.1 | 5.7 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
| 0.1 | 0.4 | GO:0007141 | male meiosis I(GO:0007141) |
| 0.1 | 1.6 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
| 0.1 | 1.2 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.1 | 1.4 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
| 0.1 | 0.2 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 0.1 | 0.5 | GO:0061037 | negative regulation of chondrocyte differentiation(GO:0032331) negative regulation of cartilage development(GO:0061037) |
| 0.1 | 4.4 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
| 0.1 | 0.5 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.1 | 1.8 | GO:0051057 | positive regulation of small GTPase mediated signal transduction(GO:0051057) |
| 0.1 | 0.5 | GO:0015871 | choline transport(GO:0015871) |
| 0.1 | 0.4 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
| 0.1 | 0.1 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.1 | 0.4 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
| 0.1 | 0.1 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 0.1 | 0.6 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
| 0.1 | 0.1 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
| 0.1 | 0.6 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
| 0.1 | 0.1 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
| 0.1 | 0.5 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
| 0.1 | 2.8 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
| 0.1 | 0.5 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.1 | 0.2 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
| 0.1 | 0.8 | GO:0003341 | cilium movement(GO:0003341) |
| 0.1 | 0.1 | GO:1902563 | regulation of neutrophil activation(GO:1902563) |
| 0.1 | 0.5 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
| 0.1 | 0.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
| 0.1 | 1.3 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.1 | 0.1 | GO:0036034 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
| 0.1 | 0.9 | GO:1903307 | positive regulation of regulated secretory pathway(GO:1903307) |
| 0.1 | 0.3 | GO:0042418 | epinephrine metabolic process(GO:0042414) epinephrine biosynthetic process(GO:0042418) |
| 0.1 | 0.6 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
| 0.1 | 0.9 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.1 | 0.7 | GO:0097503 | sialylation(GO:0097503) |
| 0.1 | 0.2 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.1 | 0.4 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.1 | 0.1 | GO:0016093 | polyprenol metabolic process(GO:0016093) |
| 0.1 | 1.1 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
| 0.1 | 0.4 | GO:0048311 | mitochondrion distribution(GO:0048311) |
| 0.1 | 0.5 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.1 | 0.5 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.1 | 0.2 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 0.1 | 0.1 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.1 | 0.7 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.1 | 0.9 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.1 | 0.9 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.1 | 0.3 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 0.1 | 0.2 | GO:0072160 | nephron tubule epithelial cell differentiation(GO:0072160) |
| 0.1 | 0.7 | GO:0007019 | microtubule depolymerization(GO:0007019) |
| 0.1 | 0.2 | GO:0098781 | ncRNA transcription(GO:0098781) |
| 0.1 | 0.3 | GO:0019079 | viral genome replication(GO:0019079) |
| 0.1 | 2.2 | GO:0007018 | microtubule-based movement(GO:0007018) |
| 0.1 | 0.4 | GO:0008228 | opsonization(GO:0008228) |
| 0.0 | 0.2 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
| 0.0 | 0.8 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.0 | 0.5 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
| 0.0 | 0.8 | GO:0006828 | manganese ion transport(GO:0006828) |
| 0.0 | 0.1 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
| 0.0 | 1.1 | GO:0001578 | microtubule bundle formation(GO:0001578) |
| 0.0 | 0.1 | GO:0009726 | detection of endogenous stimulus(GO:0009726) |
| 0.0 | 0.6 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.0 | 0.7 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
| 0.0 | 0.3 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
| 0.0 | 1.4 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.0 | 0.1 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
| 0.0 | 0.4 | GO:0035306 | positive regulation of dephosphorylation(GO:0035306) positive regulation of protein dephosphorylation(GO:0035307) |
| 0.0 | 0.1 | GO:0097254 | renal tubular secretion(GO:0097254) |
| 0.0 | 0.4 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
| 0.0 | 0.4 | GO:0006528 | asparagine metabolic process(GO:0006528) |
| 0.0 | 0.1 | GO:0032470 | positive regulation of endoplasmic reticulum calcium ion concentration(GO:0032470) |
| 0.0 | 0.1 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 0.0 | 0.4 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.0 | 0.2 | GO:0007398 | ectoderm development(GO:0007398) |
| 0.0 | 0.2 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 0.0 | 0.6 | GO:0031034 | myosin filament assembly(GO:0031034) |
| 0.0 | 2.1 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
| 0.0 | 0.1 | GO:0050951 | detection of temperature stimulus(GO:0016048) sensory perception of temperature stimulus(GO:0050951) |
| 0.0 | 0.3 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.0 | 0.1 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.0 | 0.4 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
| 0.0 | 0.1 | GO:0048075 | positive regulation of eye pigmentation(GO:0048075) |
| 0.0 | 0.2 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 0.0 | 0.4 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
| 0.0 | 0.5 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
| 0.0 | 0.5 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
| 0.0 | 0.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.0 | 0.2 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
| 0.0 | 0.4 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
| 0.0 | 0.1 | GO:0006540 | glutamate decarboxylation to succinate(GO:0006540) |
| 0.0 | 0.1 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) |
| 0.0 | 0.7 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.0 | 0.4 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.0 | 0.2 | GO:0009099 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.0 | 0.1 | GO:0042756 | drinking behavior(GO:0042756) |
| 0.0 | 0.1 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.0 | 0.1 | GO:0051147 | regulation of muscle cell differentiation(GO:0051147) |
| 0.0 | 0.2 | GO:0045023 | G0 to G1 transition(GO:0045023) |
| 0.0 | 0.1 | GO:0008212 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
| 0.0 | 0.1 | GO:0046606 | negative regulation of centrosome cycle(GO:0046606) |
| 0.0 | 1.0 | GO:0030279 | negative regulation of ossification(GO:0030279) |
| 0.0 | 1.1 | GO:0045010 | actin nucleation(GO:0045010) |
| 0.0 | 0.3 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
| 0.0 | 0.3 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
| 0.0 | 0.1 | GO:0002155 | regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
| 0.0 | 0.3 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
| 0.0 | 0.2 | GO:0032196 | transposition(GO:0032196) |
| 0.0 | 0.2 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.0 | 0.6 | GO:0048477 | oogenesis(GO:0048477) |
| 0.0 | 0.8 | GO:0005980 | glycogen catabolic process(GO:0005980) |
| 0.0 | 0.5 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.0 | 0.2 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.0 | 0.3 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
| 0.0 | 0.2 | GO:0001881 | receptor recycling(GO:0001881) |
| 0.0 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
| 0.0 | 0.1 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.0 | 0.2 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
| 0.0 | 0.0 | GO:2001225 | regulation of chloride transport(GO:2001225) |
| 0.0 | 0.5 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
| 0.0 | 1.0 | GO:0070646 | protein deubiquitination(GO:0016579) protein modification by small protein removal(GO:0070646) |
| 0.0 | 0.1 | GO:0006574 | valine catabolic process(GO:0006574) |
| 0.0 | 0.8 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
| 0.0 | 0.2 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.0 | 0.1 | GO:0044245 | polysaccharide digestion(GO:0044245) |
| 0.0 | 0.1 | GO:0006591 | ornithine metabolic process(GO:0006591) |
| 0.0 | 0.1 | GO:0086016 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) |
| 0.0 | 0.3 | GO:0006665 | sphingolipid metabolic process(GO:0006665) |
| 0.0 | 0.2 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.0 | 0.0 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.0 | 0.1 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
| 0.0 | 0.0 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 0.0 | 0.0 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.0 | 0.0 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
| 0.0 | 0.3 | GO:0034389 | lipid particle organization(GO:0034389) |
| 0.0 | 0.2 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
| 0.0 | 0.1 | GO:0031112 | positive regulation of microtubule polymerization or depolymerization(GO:0031112) positive regulation of microtubule polymerization(GO:0031116) |
| 0.0 | 0.2 | GO:0015872 | dopamine transport(GO:0015872) |
| 0.0 | 0.1 | GO:0042448 | progesterone metabolic process(GO:0042448) |
| 0.0 | 0.0 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
| 0.0 | 0.1 | GO:0015732 | prostaglandin transport(GO:0015732) |
| 0.0 | 0.6 | GO:0006970 | response to osmotic stress(GO:0006970) |
| 0.0 | 0.2 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.0 | 0.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.0 | 0.2 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
| 0.0 | 0.4 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
| 0.0 | 0.1 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
| 0.0 | 0.6 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.0 | 0.0 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 0.0 | 0.0 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.2 | 15.5 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 3.5 | 24.4 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 2.9 | 14.3 | GO:0005726 | perichromatin fibrils(GO:0005726) |
| 2.7 | 18.9 | GO:0016589 | NURF complex(GO:0016589) |
| 2.5 | 10.0 | GO:0044094 | host cell nucleus(GO:0042025) host cell nuclear part(GO:0044094) |
| 2.4 | 23.8 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 2.3 | 11.4 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 2.1 | 8.6 | GO:0097224 | sperm connecting piece(GO:0097224) |
| 2.1 | 14.6 | GO:0001520 | outer dense fiber(GO:0001520) |
| 2.0 | 6.0 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
| 1.9 | 5.7 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
| 1.9 | 13.2 | GO:0072487 | MSL complex(GO:0072487) |
| 1.9 | 16.8 | GO:0005955 | calcineurin complex(GO:0005955) |
| 1.8 | 5.4 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
| 1.8 | 12.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 1.8 | 7.0 | GO:0031417 | NatC complex(GO:0031417) |
| 1.7 | 1.7 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
| 1.7 | 39.7 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 1.7 | 11.6 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 1.6 | 6.5 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 1.6 | 1.6 | GO:0032009 | early phagosome(GO:0032009) |
| 1.6 | 6.2 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 1.5 | 13.8 | GO:0035102 | PRC1 complex(GO:0035102) |
| 1.5 | 4.5 | GO:0001740 | Barr body(GO:0001740) |
| 1.4 | 7.1 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
| 1.4 | 6.9 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
| 1.3 | 1.3 | GO:0097134 | cyclin E1-CDK2 complex(GO:0097134) |
| 1.3 | 3.9 | GO:0031010 | ISWI-type complex(GO:0031010) |
| 1.2 | 11.1 | GO:0032039 | integrator complex(GO:0032039) |
| 1.2 | 4.8 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 1.2 | 3.5 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 1.2 | 43.3 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
| 1.2 | 10.4 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
| 1.2 | 9.2 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 1.1 | 4.6 | GO:0070695 | FHF complex(GO:0070695) |
| 1.1 | 16.9 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 1.1 | 12.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 1.1 | 5.5 | GO:0030891 | VCB complex(GO:0030891) |
| 1.1 | 3.3 | GO:1990298 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
| 1.1 | 8.7 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 1.1 | 7.5 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 1.1 | 25.4 | GO:0071564 | npBAF complex(GO:0071564) |
| 1.1 | 3.2 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 1.0 | 14.7 | GO:0042575 | DNA polymerase complex(GO:0042575) |
| 1.0 | 3.1 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 1.0 | 10.4 | GO:0000124 | SAGA complex(GO:0000124) |
| 1.0 | 3.1 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
| 1.0 | 25.9 | GO:0031519 | PcG protein complex(GO:0031519) |
| 1.0 | 5.0 | GO:0071565 | nBAF complex(GO:0071565) |
| 1.0 | 13.0 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 1.0 | 1.0 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 1.0 | 10.9 | GO:0033391 | chromatoid body(GO:0033391) |
| 1.0 | 48.8 | GO:1990391 | DNA repair complex(GO:1990391) |
| 0.9 | 4.7 | GO:0032449 | CBM complex(GO:0032449) |
| 0.9 | 10.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.9 | 9.7 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.9 | 14.9 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.9 | 4.3 | GO:0001652 | granular component(GO:0001652) |
| 0.9 | 1.7 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.9 | 1.7 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.8 | 11.0 | GO:0097227 | sperm annulus(GO:0097227) |
| 0.8 | 0.8 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.8 | 7.5 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.8 | 2.5 | GO:0060187 | cell pole(GO:0060187) |
| 0.8 | 4.9 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.8 | 2.5 | GO:0034657 | GID complex(GO:0034657) |
| 0.8 | 4.1 | GO:0036398 | TCR signalosome(GO:0036398) |
| 0.8 | 13.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.8 | 0.8 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
| 0.8 | 42.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.8 | 8.7 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 0.8 | 22.6 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.8 | 6.1 | GO:0000322 | storage vacuole(GO:0000322) |
| 0.8 | 3.0 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
| 0.7 | 4.5 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
| 0.7 | 7.3 | GO:0032156 | septin cytoskeleton(GO:0032156) |
| 0.7 | 1.5 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 0.7 | 6.5 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.7 | 10.1 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.7 | 0.7 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
| 0.7 | 2.8 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 0.7 | 0.7 | GO:0070603 | SWI/SNF superfamily-type complex(GO:0070603) |
| 0.7 | 4.8 | GO:0090544 | BAF-type complex(GO:0090544) |
| 0.7 | 8.2 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.7 | 11.5 | GO:0070822 | Sin3-type complex(GO:0070822) |
| 0.7 | 6.0 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.7 | 12.5 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.6 | 9.0 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.6 | 4.4 | GO:0061700 | GATOR2 complex(GO:0061700) |
| 0.6 | 40.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.6 | 6.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.6 | 1.9 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
| 0.6 | 1.8 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.6 | 11.9 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.6 | 1.8 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.6 | 1.7 | GO:0044305 | calyx of Held(GO:0044305) |
| 0.6 | 1.7 | GO:0030689 | Noc complex(GO:0030689) |
| 0.6 | 7.5 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.6 | 1.1 | GO:0031527 | filopodium membrane(GO:0031527) |
| 0.6 | 3.4 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 0.6 | 11.1 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
| 0.6 | 5.0 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.5 | 1.6 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
| 0.5 | 2.7 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
| 0.5 | 1.6 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
| 0.5 | 2.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.5 | 7.5 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.5 | 1.6 | GO:0005656 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
| 0.5 | 9.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.5 | 5.6 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.5 | 1.0 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
| 0.5 | 1.0 | GO:0097422 | tubular endosome(GO:0097422) |
| 0.5 | 2.0 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.5 | 0.5 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
| 0.5 | 3.4 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 0.5 | 1.0 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
| 0.5 | 4.3 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.5 | 3.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.5 | 57.6 | GO:0016363 | nuclear matrix(GO:0016363) |
| 0.4 | 1.3 | GO:0005879 | axonemal microtubule(GO:0005879) |
| 0.4 | 5.8 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.4 | 8.0 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.4 | 21.2 | GO:0016235 | aggresome(GO:0016235) |
| 0.4 | 1.7 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.4 | 1.3 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 0.4 | 49.3 | GO:0034705 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
| 0.4 | 0.4 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.4 | 14.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.4 | 10.5 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
| 0.4 | 1.3 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
| 0.4 | 7.1 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.4 | 3.7 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.4 | 0.8 | GO:0071546 | pi-body(GO:0071546) |
| 0.4 | 5.0 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.4 | 2.9 | GO:0070531 | BRCA1-A complex(GO:0070531) |
| 0.4 | 2.9 | GO:0030914 | STAGA complex(GO:0030914) |
| 0.4 | 1.2 | GO:0097447 | dendritic tree(GO:0097447) |
| 0.4 | 6.1 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.4 | 0.4 | GO:0097539 | ciliary transition fiber(GO:0097539) |
| 0.4 | 2.8 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 0.4 | 6.1 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
| 0.4 | 2.4 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.4 | 5.2 | GO:0042555 | MCM complex(GO:0042555) |
| 0.4 | 1.2 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.4 | 163.5 | GO:0016607 | nuclear speck(GO:0016607) |
| 0.4 | 1.2 | GO:0010369 | chromocenter(GO:0010369) |
| 0.4 | 7.4 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.4 | 28.1 | GO:0016605 | PML body(GO:0016605) |
| 0.4 | 5.1 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.4 | 1.2 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.4 | 6.4 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
| 0.4 | 13.2 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
| 0.4 | 1.5 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.4 | 2.2 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 0.4 | 3.3 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.4 | 1.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 0.4 | 2.9 | GO:0001673 | male germ cell nucleus(GO:0001673) |
| 0.4 | 5.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.4 | 0.7 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
| 0.4 | 1.8 | GO:0017102 | methionyl glutamyl tRNA synthetase complex(GO:0017102) |
| 0.4 | 1.4 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.4 | 1.4 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.4 | 0.7 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.4 | 1.1 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.4 | 1.1 | GO:0043291 | RAVE complex(GO:0043291) |
| 0.4 | 1.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.3 | 2.8 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
| 0.3 | 1.0 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 0.3 | 0.3 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 0.3 | 3.1 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
| 0.3 | 1.4 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
| 0.3 | 1.7 | GO:0036128 | CatSper complex(GO:0036128) |
| 0.3 | 0.7 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
| 0.3 | 0.7 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
| 0.3 | 1.3 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.3 | 2.0 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.3 | 17.1 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.3 | 53.9 | GO:0000793 | condensed chromosome(GO:0000793) |
| 0.3 | 103.4 | GO:0000785 | chromatin(GO:0000785) |
| 0.3 | 5.2 | GO:0032059 | bleb(GO:0032059) |
| 0.3 | 3.6 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 0.3 | 1.3 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
| 0.3 | 2.3 | GO:0060091 | kinocilium(GO:0060091) |
| 0.3 | 1.3 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 0.3 | 4.5 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.3 | 57.7 | GO:0005694 | chromosome(GO:0005694) |
| 0.3 | 2.6 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.3 | 2.2 | GO:0090543 | Flemming body(GO:0090543) |
| 0.3 | 5.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.3 | 2.8 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.3 | 0.6 | GO:0044308 | axonal spine(GO:0044308) |
| 0.3 | 2.1 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
| 0.3 | 0.9 | GO:0070081 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
| 0.3 | 1.8 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
| 0.3 | 3.9 | GO:0097546 | ciliary base(GO:0097546) |
| 0.3 | 6.0 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.3 | 1.2 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.3 | 1.7 | GO:0044294 | dendrite terminus(GO:0044292) dendritic growth cone(GO:0044294) |
| 0.3 | 0.9 | GO:0030904 | retromer complex(GO:0030904) |
| 0.3 | 0.9 | GO:0005844 | polysome(GO:0005844) |
| 0.3 | 0.6 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 0.3 | 9.9 | GO:0097542 | ciliary tip(GO:0097542) |
| 0.3 | 2.5 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.3 | 1.7 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 0.3 | 1.9 | GO:0000439 | core TFIIH complex(GO:0000439) |
| 0.3 | 1.4 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.3 | 3.3 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.3 | 2.2 | GO:0098845 | postsynaptic endosome(GO:0098845) |
| 0.3 | 1.1 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
| 0.3 | 0.8 | GO:0031251 | PAN complex(GO:0031251) |
| 0.3 | 5.5 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.3 | 3.4 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.3 | 0.3 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
| 0.3 | 8.8 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.3 | 0.3 | GO:0055087 | Ski complex(GO:0055087) |
| 0.3 | 3.6 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 0.3 | 0.3 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 0.3 | 0.8 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 0.3 | 1.0 | GO:0032437 | cuticular plate(GO:0032437) |
| 0.2 | 1.7 | GO:0034464 | BBSome(GO:0034464) |
| 0.2 | 3.7 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.2 | 1.7 | GO:0031415 | NatA complex(GO:0031415) |
| 0.2 | 3.6 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.2 | 51.0 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
| 0.2 | 1.4 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
| 0.2 | 4.7 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.2 | 2.6 | GO:0043083 | synaptic cleft(GO:0043083) |
| 0.2 | 1.6 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.2 | 2.1 | GO:0016013 | syntrophin complex(GO:0016013) |
| 0.2 | 1.6 | GO:0036020 | endolysosome membrane(GO:0036020) |
| 0.2 | 6.2 | GO:0030673 | axolemma(GO:0030673) |
| 0.2 | 5.7 | GO:0034399 | nuclear periphery(GO:0034399) |
| 0.2 | 6.6 | GO:0015030 | Cajal body(GO:0015030) |
| 0.2 | 1.6 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
| 0.2 | 33.3 | GO:0035770 | ribonucleoprotein granule(GO:0035770) |
| 0.2 | 1.1 | GO:0000938 | GARP complex(GO:0000938) |
| 0.2 | 1.1 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
| 0.2 | 0.4 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.2 | 0.6 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.2 | 1.3 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
| 0.2 | 0.9 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.2 | 16.7 | GO:0005814 | centriole(GO:0005814) |
| 0.2 | 3.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.2 | 2.9 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.2 | 4.5 | GO:0030427 | site of polarized growth(GO:0030427) |
| 0.2 | 10.7 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
| 0.2 | 3.0 | GO:0032420 | stereocilium(GO:0032420) |
| 0.2 | 0.8 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.2 | 1.7 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.2 | 2.9 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
| 0.2 | 1.7 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.2 | 1.1 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.2 | 2.3 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 0.2 | 1.7 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.2 | 4.3 | GO:0008021 | synaptic vesicle(GO:0008021) |
| 0.2 | 2.2 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
| 0.2 | 1.3 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.2 | 0.7 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.2 | 1.1 | GO:0005675 | holo TFIIH complex(GO:0005675) |
| 0.2 | 0.9 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
| 0.2 | 3.0 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.2 | 0.5 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.2 | 2.7 | GO:0044447 | axoneme part(GO:0044447) |
| 0.2 | 1.0 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.2 | 1.1 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.2 | 4.8 | GO:0015630 | microtubule cytoskeleton(GO:0015630) |
| 0.2 | 0.2 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
| 0.2 | 0.8 | GO:0032280 | symmetric synapse(GO:0032280) |
| 0.2 | 5.1 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
| 0.2 | 0.8 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 0.2 | 0.8 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 0.1 | 0.6 | GO:0002177 | manchette(GO:0002177) |
| 0.1 | 0.9 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.1 | 0.3 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
| 0.1 | 0.7 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.1 | 0.7 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 0.1 | 0.6 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
| 0.1 | 0.3 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 0.1 | 3.0 | GO:0016592 | mediator complex(GO:0016592) |
| 0.1 | 1.2 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.1 | 3.1 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.1 | 0.5 | GO:0043235 | receptor complex(GO:0043235) |
| 0.1 | 2.0 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.1 | 1.0 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
| 0.1 | 0.8 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.1 | 0.3 | GO:0035838 | growing cell tip(GO:0035838) |
| 0.1 | 5.7 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.1 | 0.4 | GO:0072534 | perineuronal net(GO:0072534) |
| 0.1 | 0.4 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.1 | 1.4 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
| 0.1 | 1.4 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.1 | 3.0 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.1 | 1.2 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.1 | 7.7 | GO:0000922 | spindle pole(GO:0000922) |
| 0.1 | 2.0 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
| 0.1 | 0.6 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.1 | 0.5 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.1 | 0.8 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.1 | 0.3 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
| 0.1 | 0.4 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
| 0.1 | 1.3 | GO:0030118 | clathrin coat(GO:0030118) |
| 0.1 | 76.3 | GO:0005730 | nucleolus(GO:0005730) |
| 0.1 | 1.0 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.1 | 0.4 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.1 | 0.7 | GO:0042584 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
| 0.1 | 0.6 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
| 0.1 | 0.4 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
| 0.1 | 0.3 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 0.1 | 19.9 | GO:0031965 | nuclear membrane(GO:0031965) |
| 0.1 | 3.2 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.1 | 0.4 | GO:0043293 | apoptosome(GO:0043293) |
| 0.1 | 0.5 | GO:0034704 | calcium channel complex(GO:0034704) |
| 0.1 | 0.5 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 0.1 | 1.2 | GO:0030018 | Z disc(GO:0030018) |
| 0.1 | 1.1 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.1 | 0.8 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
| 0.1 | 0.2 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
| 0.1 | 1.0 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.1 | 1.6 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
| 0.1 | 0.8 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.1 | 0.4 | GO:0005865 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
| 0.1 | 2.8 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.1 | 4.5 | GO:0005875 | microtubule associated complex(GO:0005875) |
| 0.1 | 1.5 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.1 | 2.5 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 0.1 | 0.5 | GO:0005923 | bicellular tight junction(GO:0005923) |
| 0.1 | 0.2 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.1 | 2.4 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.1 | 0.3 | GO:0031932 | TORC2 complex(GO:0031932) TOR complex(GO:0038201) |
| 0.1 | 3.8 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.1 | 3.2 | GO:0043204 | perikaryon(GO:0043204) |
| 0.1 | 3.6 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.1 | 0.4 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.1 | 0.3 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.1 | 0.4 | GO:0016459 | myosin complex(GO:0016459) |
| 0.1 | 3.1 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 0.1 | 0.7 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
| 0.1 | 2.2 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.1 | 2.9 | GO:0005667 | transcription factor complex(GO:0005667) |
| 0.1 | 0.2 | GO:0032421 | stereocilium bundle(GO:0032421) |
| 0.1 | 0.7 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.1 | 7.5 | GO:0005929 | cilium(GO:0005929) |
| 0.1 | 108.4 | GO:0005654 | nucleoplasm(GO:0005654) |
| 0.1 | 1.0 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.1 | 1.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.0 | 2.7 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.0 | 0.2 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.0 | 0.2 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.0 | 0.1 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
| 0.0 | 3.6 | GO:0019867 | outer membrane(GO:0019867) |
| 0.0 | 88.5 | GO:0005634 | nucleus(GO:0005634) |
| 0.0 | 0.2 | GO:0002169 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
| 0.0 | 1.1 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.0 | 0.1 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 0.0 | 0.6 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 0.0 | 0.1 | GO:0018444 | translation release factor complex(GO:0018444) |
| 0.0 | 0.2 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 0.0 | 0.2 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
| 0.0 | 0.5 | GO:0032982 | myosin filament(GO:0032982) |
| 0.0 | 0.1 | GO:0070382 | exocytic vesicle(GO:0070382) |
| 0.0 | 0.3 | GO:0016460 | myosin II complex(GO:0016460) |
| 0.0 | 0.7 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.0 | 0.1 | GO:0045178 | basal part of cell(GO:0045178) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 8.8 | 26.3 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
| 5.2 | 15.5 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 2.9 | 8.6 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
| 2.8 | 24.9 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
| 2.7 | 8.1 | GO:0004103 | choline kinase activity(GO:0004103) |
| 2.7 | 8.0 | GO:0035501 | MH1 domain binding(GO:0035501) |
| 2.7 | 26.7 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 2.3 | 13.7 | GO:0023030 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
| 2.2 | 27.0 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
| 2.2 | 6.7 | GO:0031859 | platelet activating factor receptor binding(GO:0031859) |
| 2.1 | 23.6 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
| 2.1 | 6.4 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
| 2.1 | 6.4 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
| 2.1 | 6.3 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
| 2.0 | 36.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 1.9 | 7.6 | GO:0038025 | reelin receptor activity(GO:0038025) |
| 1.9 | 7.6 | GO:0031208 | POZ domain binding(GO:0031208) |
| 1.9 | 56.7 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 1.9 | 9.3 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
| 1.9 | 20.4 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
| 1.8 | 9.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 1.8 | 7.1 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
| 1.8 | 8.8 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 1.7 | 11.8 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 1.7 | 8.3 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 1.6 | 4.8 | GO:0047322 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
| 1.6 | 9.4 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 1.6 | 11.0 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 1.5 | 87.9 | GO:0004407 | histone deacetylase activity(GO:0004407) |
| 1.5 | 10.8 | GO:0050733 | RS domain binding(GO:0050733) |
| 1.5 | 9.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 1.5 | 6.1 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 1.5 | 4.4 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 1.5 | 7.3 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 1.4 | 4.3 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 1.4 | 4.3 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
| 1.4 | 8.4 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 1.4 | 7.0 | GO:0008486 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
| 1.4 | 19.4 | GO:0003680 | AT DNA binding(GO:0003680) |
| 1.4 | 20.6 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 1.4 | 4.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
| 1.4 | 8.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 1.4 | 15.0 | GO:0034056 | estrogen response element binding(GO:0034056) |
| 1.3 | 47.1 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 1.3 | 4.0 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
| 1.3 | 4.0 | GO:0031877 | somatostatin receptor binding(GO:0031877) |
| 1.3 | 5.2 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
| 1.3 | 9.0 | GO:0008142 | oxysterol binding(GO:0008142) |
| 1.3 | 10.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 1.3 | 6.4 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 1.2 | 13.6 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
| 1.2 | 4.9 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 1.2 | 19.2 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
| 1.2 | 13.1 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
| 1.1 | 9.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 1.1 | 1.1 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 1.1 | 4.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 1.1 | 11.4 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 1.1 | 9.1 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 1.1 | 3.4 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 1.1 | 4.5 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 1.1 | 17.6 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 1.1 | 4.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 1.1 | 14.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 1.1 | 1.1 | GO:0050436 | microfibril binding(GO:0050436) |
| 1.1 | 6.4 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
| 1.1 | 4.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 1.0 | 3.1 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
| 1.0 | 16.9 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 1.0 | 31.6 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 1.0 | 4.0 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
| 1.0 | 5.9 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 1.0 | 21.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 1.0 | 8.8 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 1.0 | 13.6 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
| 1.0 | 6.7 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
| 1.0 | 2.9 | GO:0036033 | mediator complex binding(GO:0036033) |
| 0.9 | 7.5 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
| 0.9 | 4.7 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.9 | 15.0 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 0.9 | 3.7 | GO:0032143 | single thymine insertion binding(GO:0032143) |
| 0.9 | 21.3 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
| 0.9 | 10.1 | GO:0000150 | recombinase activity(GO:0000150) |
| 0.9 | 9.9 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.9 | 16.0 | GO:0005522 | profilin binding(GO:0005522) |
| 0.9 | 10.6 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.9 | 3.4 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.9 | 1.7 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
| 0.9 | 3.4 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
| 0.9 | 2.6 | GO:0015218 | pyrimidine nucleotide transmembrane transporter activity(GO:0015218) |
| 0.8 | 4.2 | GO:0004883 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
| 0.8 | 18.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.8 | 1.7 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 0.8 | 4.9 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.8 | 2.5 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.8 | 6.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.8 | 4.8 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
| 0.8 | 2.4 | GO:0004756 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
| 0.8 | 2.4 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 0.8 | 2.4 | GO:0036317 | tyrosyl-RNA phosphodiesterase activity(GO:0036317) 5'-tyrosyl-DNA phosphodiesterase activity(GO:0070260) |
| 0.8 | 7.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
| 0.8 | 3.9 | GO:0046592 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
| 0.8 | 12.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.8 | 12.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.8 | 5.3 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.8 | 0.8 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 0.8 | 1.5 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.8 | 2.3 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 0.8 | 9.8 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
| 0.8 | 2.3 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 0.7 | 8.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.7 | 2.2 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
| 0.7 | 3.7 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
| 0.7 | 0.7 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
| 0.7 | 0.7 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.7 | 3.6 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 0.7 | 10.0 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.7 | 8.6 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 0.7 | 2.8 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
| 0.7 | 4.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.7 | 19.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.7 | 10.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.7 | 4.8 | GO:0003678 | DNA helicase activity(GO:0003678) |
| 0.7 | 4.1 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
| 0.7 | 21.8 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.7 | 3.4 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.7 | 2.7 | GO:0004803 | transposase activity(GO:0004803) |
| 0.7 | 4.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.7 | 32.2 | GO:0035064 | methylated histone binding(GO:0035064) |
| 0.7 | 3.3 | GO:0004337 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
| 0.7 | 3.3 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.7 | 4.6 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
| 0.6 | 3.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.6 | 4.5 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
| 0.6 | 5.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.6 | 14.5 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 0.6 | 6.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.6 | 1.9 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.6 | 15.1 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.6 | 1.9 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 0.6 | 6.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.6 | 10.4 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.6 | 23.3 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.6 | 2.4 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 0.6 | 6.7 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.6 | 1.8 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.6 | 20.3 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.6 | 12.5 | GO:0000339 | RNA cap binding(GO:0000339) |
| 0.6 | 8.9 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.6 | 5.3 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.6 | 2.3 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 0.6 | 2.9 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
| 0.6 | 5.2 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.6 | 16.3 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.6 | 1.7 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
| 0.6 | 2.3 | GO:0032406 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
| 0.6 | 10.3 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.6 | 5.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.6 | 1.7 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
| 0.5 | 2.2 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
| 0.5 | 1.6 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
| 0.5 | 6.6 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
| 0.5 | 0.5 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 0.5 | 11.3 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.5 | 3.2 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
| 0.5 | 1.6 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 0.5 | 1.6 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
| 0.5 | 8.5 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 0.5 | 1.6 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
| 0.5 | 17.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.5 | 3.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 0.5 | 42.1 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
| 0.5 | 4.1 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.5 | 3.0 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 0.5 | 1.5 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
| 0.5 | 27.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.5 | 3.5 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.5 | 5.5 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.5 | 3.4 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.5 | 1.9 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
| 0.5 | 5.3 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.5 | 37.6 | GO:0042393 | histone binding(GO:0042393) |
| 0.5 | 1.4 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
| 0.5 | 88.6 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
| 0.5 | 6.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.5 | 4.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.5 | 2.3 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.5 | 2.8 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.5 | 26.9 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
| 0.5 | 1.8 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 0.5 | 10.6 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.5 | 1.4 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
| 0.5 | 1.4 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 0.5 | 6.0 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 0.5 | 1.4 | GO:0001181 | transcription factor activity, core RNA polymerase I binding(GO:0001181) |
| 0.5 | 1.8 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
| 0.4 | 1.8 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.4 | 1.3 | GO:0015230 | FAD transmembrane transporter activity(GO:0015230) coenzyme transporter activity(GO:0051185) |
| 0.4 | 5.7 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 0.4 | 1.7 | GO:0019826 | oxygen sensor activity(GO:0019826) |
| 0.4 | 3.0 | GO:0043559 | insulin binding(GO:0043559) |
| 0.4 | 1.7 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
| 0.4 | 8.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.4 | 1.3 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.4 | 14.1 | GO:0004402 | histone acetyltransferase activity(GO:0004402) peptide-lysine-N-acetyltransferase activity(GO:0061733) |
| 0.4 | 5.9 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
| 0.4 | 1.7 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 0.4 | 1.7 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 0.4 | 3.7 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.4 | 5.4 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.4 | 1.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 0.4 | 4.1 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
| 0.4 | 2.4 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
| 0.4 | 15.2 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.4 | 36.6 | GO:0004386 | helicase activity(GO:0004386) |
| 0.4 | 13.0 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 0.4 | 2.0 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
| 0.4 | 2.0 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
| 0.4 | 1.2 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
| 0.4 | 1.6 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
| 0.4 | 29.5 | GO:0043130 | ubiquitin binding(GO:0043130) |
| 0.4 | 2.3 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
| 0.4 | 1.5 | GO:0005277 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
| 0.4 | 3.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.4 | 7.5 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 0.4 | 1.9 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
| 0.4 | 2.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.4 | 1.9 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
| 0.4 | 3.0 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 0.4 | 4.1 | GO:0019957 | C-C chemokine binding(GO:0019957) |
| 0.4 | 1.5 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
| 0.4 | 1.1 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
| 0.4 | 1.1 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
| 0.4 | 3.0 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.4 | 2.2 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 0.4 | 3.3 | GO:0032452 | histone demethylase activity(GO:0032452) |
| 0.4 | 0.4 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 0.4 | 1.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
| 0.4 | 8.3 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.4 | 3.2 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.4 | 2.5 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.4 | 2.1 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.4 | 1.4 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.4 | 4.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.3 | 1.4 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 0.3 | 3.8 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.3 | 2.8 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
| 0.3 | 6.9 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
| 0.3 | 8.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.3 | 1.0 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
| 0.3 | 7.1 | GO:0048487 | beta-tubulin binding(GO:0048487) |
| 0.3 | 2.4 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
| 0.3 | 1.0 | GO:0015361 | low-affinity sodium:dicarboxylate symporter activity(GO:0015361) |
| 0.3 | 1.7 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.3 | 1.3 | GO:0043426 | MRF binding(GO:0043426) |
| 0.3 | 10.0 | GO:0030371 | translation repressor activity(GO:0030371) |
| 0.3 | 4.4 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.3 | 8.4 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.3 | 0.7 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.3 | 18.3 | GO:0030276 | clathrin binding(GO:0030276) |
| 0.3 | 1.7 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
| 0.3 | 4.0 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.3 | 23.4 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
| 0.3 | 2.3 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.3 | 1.6 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
| 0.3 | 2.0 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.3 | 0.7 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
| 0.3 | 8.4 | GO:0070063 | RNA polymerase binding(GO:0070063) |
| 0.3 | 1.6 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
| 0.3 | 0.6 | GO:1904315 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
| 0.3 | 1.2 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
| 0.3 | 0.3 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 0.3 | 0.3 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.3 | 6.4 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.3 | 7.0 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.3 | 0.9 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
| 0.3 | 0.9 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
| 0.3 | 1.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 0.3 | 1.2 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.3 | 0.9 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.3 | 3.6 | GO:0008327 | methyl-CpG binding(GO:0008327) |
| 0.3 | 3.3 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
| 0.3 | 0.9 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
| 0.3 | 0.9 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
| 0.3 | 0.9 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
| 0.3 | 2.9 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 0.3 | 20.1 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 0.3 | 0.9 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
| 0.3 | 0.6 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 0.3 | 0.6 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
| 0.3 | 1.7 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.3 | 19.7 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.3 | 2.8 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.3 | 0.6 | GO:0016004 | phospholipase activator activity(GO:0016004) |
| 0.3 | 0.8 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 0.3 | 5.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.3 | 1.4 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
| 0.3 | 0.8 | GO:0005174 | CD40 receptor binding(GO:0005174) |
| 0.3 | 1.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.3 | 3.1 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
| 0.3 | 6.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.3 | 4.9 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
| 0.3 | 2.7 | GO:0052744 | phosphatidylinositol-3-phosphatase activity(GO:0004438) phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
| 0.3 | 2.7 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.3 | 0.8 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
| 0.3 | 0.8 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
| 0.3 | 5.7 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.3 | 3.9 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.3 | 0.5 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
| 0.3 | 5.2 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.3 | 21.2 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
| 0.3 | 1.0 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 0.3 | 1.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.3 | 21.0 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
| 0.3 | 10.8 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.2 | 3.0 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.2 | 3.0 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
| 0.2 | 5.2 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.2 | 2.7 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.2 | 1.9 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 0.2 | 1.0 | GO:0001727 | lipid kinase activity(GO:0001727) |
| 0.2 | 1.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.2 | 1.2 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 0.2 | 1.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.2 | 1.0 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.2 | 2.6 | GO:0042826 | histone deacetylase binding(GO:0042826) |
| 0.2 | 6.9 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.2 | 1.4 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
| 0.2 | 0.7 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
| 0.2 | 1.6 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.2 | 0.7 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 0.2 | 0.7 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
| 0.2 | 1.3 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 0.2 | 1.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 0.2 | 3.3 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
| 0.2 | 1.3 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
| 0.2 | 0.4 | GO:0051379 | alpha2-adrenergic receptor activity(GO:0004938) epinephrine binding(GO:0051379) |
| 0.2 | 0.9 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
| 0.2 | 0.6 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
| 0.2 | 3.4 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
| 0.2 | 3.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.2 | 1.5 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
| 0.2 | 2.3 | GO:0031386 | protein tag(GO:0031386) |
| 0.2 | 1.2 | GO:0042610 | CD8 receptor binding(GO:0042610) |
| 0.2 | 1.0 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.2 | 2.3 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.2 | 0.8 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.2 | 2.0 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.2 | 5.0 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.2 | 2.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.2 | 0.6 | GO:0070878 | primary miRNA binding(GO:0070878) |
| 0.2 | 5.7 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.2 | 0.6 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
| 0.2 | 0.8 | GO:0005267 | potassium channel activity(GO:0005267) |
| 0.2 | 1.2 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
| 0.2 | 0.6 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
| 0.2 | 2.1 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
| 0.2 | 9.3 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
| 0.2 | 3.4 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.2 | 1.3 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
| 0.2 | 1.1 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 0.2 | 0.9 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
| 0.2 | 5.0 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.2 | 1.6 | GO:0070411 | I-SMAD binding(GO:0070411) |
| 0.2 | 2.5 | GO:0009881 | photoreceptor activity(GO:0009881) |
| 0.2 | 1.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.2 | 0.5 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.2 | 1.3 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 0.2 | 0.7 | GO:0004998 | transferrin receptor activity(GO:0004998) |
| 0.2 | 0.7 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.2 | 0.7 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 0.2 | 1.6 | GO:0032190 | acrosin binding(GO:0032190) |
| 0.2 | 1.9 | GO:0015266 | protein channel activity(GO:0015266) |
| 0.2 | 0.9 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
| 0.2 | 1.2 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) L-lactate dehydrogenase activity(GO:0004459) |
| 0.2 | 0.7 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.2 | 1.4 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.2 | 1.5 | GO:0042301 | phosphate ion binding(GO:0042301) |
| 0.2 | 1.7 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
| 0.2 | 0.3 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 0.2 | 0.2 | GO:0035197 | siRNA binding(GO:0035197) |
| 0.2 | 1.2 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
| 0.2 | 3.5 | GO:0003682 | chromatin binding(GO:0003682) |
| 0.2 | 0.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
| 0.2 | 0.7 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
| 0.2 | 1.0 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.2 | 50.2 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.2 | 1.0 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
| 0.2 | 1.0 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 0.2 | 2.0 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.2 | 35.7 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
| 0.2 | 0.7 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.2 | 0.5 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
| 0.2 | 0.5 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.2 | 0.6 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 0.2 | 2.9 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 0.2 | 5.0 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
| 0.2 | 1.6 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
| 0.2 | 0.5 | GO:0048030 | disaccharide binding(GO:0048030) |
| 0.2 | 0.8 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.2 | 0.3 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
| 0.2 | 0.8 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
| 0.2 | 0.8 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
| 0.2 | 0.6 | GO:0097001 | ceramide binding(GO:0097001) |
| 0.2 | 0.3 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
| 0.2 | 2.1 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
| 0.2 | 5.4 | GO:0000049 | tRNA binding(GO:0000049) |
| 0.2 | 2.4 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.1 | 0.4 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
| 0.1 | 0.6 | GO:0004104 | cholinesterase activity(GO:0004104) |
| 0.1 | 5.8 | GO:0043621 | protein self-association(GO:0043621) |
| 0.1 | 1.0 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
| 0.1 | 4.5 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.1 | 0.3 | GO:0033265 | choline binding(GO:0033265) |
| 0.1 | 1.7 | GO:0031005 | filamin binding(GO:0031005) |
| 0.1 | 0.4 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
| 0.1 | 0.3 | GO:0000403 | Y-form DNA binding(GO:0000403) |
| 0.1 | 0.7 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
| 0.1 | 0.6 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
| 0.1 | 1.4 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.1 | 1.9 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
| 0.1 | 0.9 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.1 | 1.1 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
| 0.1 | 3.7 | GO:0019894 | kinesin binding(GO:0019894) |
| 0.1 | 2.0 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.1 | 0.4 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
| 0.1 | 0.8 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.1 | 1.3 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
| 0.1 | 0.4 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
| 0.1 | 0.8 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 0.1 | 1.3 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
| 0.1 | 0.4 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
| 0.1 | 0.4 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
| 0.1 | 1.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.1 | 0.6 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
| 0.1 | 0.6 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
| 0.1 | 0.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.1 | 1.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.1 | 3.2 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
| 0.1 | 0.4 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
| 0.1 | 0.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.1 | 12.3 | GO:0035591 | signaling adaptor activity(GO:0035591) |
| 0.1 | 0.5 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.1 | 0.6 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
| 0.1 | 1.5 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 0.1 | 0.9 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 0.1 | 0.5 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
| 0.1 | 0.7 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.1 | 0.8 | GO:0008373 | sialyltransferase activity(GO:0008373) |
| 0.1 | 0.4 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
| 0.1 | 1.1 | GO:0030331 | estrogen receptor binding(GO:0030331) |
| 0.1 | 169.3 | GO:0003677 | DNA binding(GO:0003677) |
| 0.1 | 0.4 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.1 | 2.6 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.1 | 0.4 | GO:0051373 | FATZ binding(GO:0051373) |
| 0.1 | 0.2 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
| 0.1 | 0.8 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.1 | 0.3 | GO:0047977 | hepoxilin-epoxide hydrolase activity(GO:0047977) |
| 0.1 | 1.9 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
| 0.1 | 0.3 | GO:0019789 | SUMO transferase activity(GO:0019789) |
| 0.1 | 0.5 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 0.1 | 1.5 | GO:0050681 | androgen receptor binding(GO:0050681) |
| 0.1 | 0.5 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
| 0.1 | 0.8 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
| 0.1 | 0.3 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.1 | 0.5 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
| 0.1 | 3.1 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 0.1 | 0.5 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.1 | 0.5 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.1 | 0.8 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.1 | 0.7 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
| 0.1 | 0.4 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
| 0.1 | 0.4 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
| 0.1 | 1.2 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
| 0.1 | 0.5 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.1 | 0.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
| 0.1 | 0.9 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.1 | 0.3 | GO:0004603 | phenylethanolamine N-methyltransferase activity(GO:0004603) |
| 0.1 | 0.4 | GO:1990460 | leptin receptor binding(GO:1990460) |
| 0.1 | 0.2 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
| 0.1 | 0.3 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
| 0.1 | 0.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
| 0.1 | 2.5 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
| 0.1 | 0.2 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.1 | 0.2 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
| 0.1 | 0.6 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 0.1 | 0.2 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
| 0.1 | 0.6 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.1 | 0.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.1 | 23.9 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
| 0.1 | 1.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.1 | 0.2 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
| 0.1 | 0.5 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 0.1 | 0.1 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.1 | 0.2 | GO:0008431 | vitamin E binding(GO:0008431) |
| 0.1 | 0.3 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
| 0.1 | 2.1 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
| 0.1 | 0.4 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
| 0.1 | 3.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.1 | 1.4 | GO:0042166 | acetylcholine binding(GO:0042166) |
| 0.1 | 0.3 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
| 0.1 | 0.1 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
| 0.1 | 0.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
| 0.1 | 1.0 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.1 | 0.7 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
| 0.1 | 0.4 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 0.1 | 1.4 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 0.1 | 1.3 | GO:0071949 | FAD binding(GO:0071949) |
| 0.1 | 0.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.1 | 0.2 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
| 0.1 | 0.3 | GO:0030553 | cGMP binding(GO:0030553) |
| 0.0 | 0.3 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.0 | 0.6 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
| 0.0 | 0.2 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 0.0 | 1.8 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.0 | 0.4 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
| 0.0 | 0.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.0 | 0.1 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.0 | 0.6 | GO:0004659 | prenyltransferase activity(GO:0004659) |
| 0.0 | 0.2 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
| 0.0 | 0.3 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.0 | 1.6 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.0 | 0.1 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
| 0.0 | 0.2 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
| 0.0 | 0.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 0.0 | 0.4 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.0 | 0.5 | GO:0019213 | deacetylase activity(GO:0019213) |
| 0.0 | 0.3 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
| 0.0 | 0.1 | GO:0004935 | adrenergic receptor activity(GO:0004935) alpha-adrenergic receptor activity(GO:0004936) alpha1-adrenergic receptor activity(GO:0004937) |
| 0.0 | 0.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
| 0.0 | 0.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.0 | 0.4 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
| 0.0 | 0.5 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.0 | 0.2 | GO:0052655 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.0 | 0.3 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 0.0 | 0.3 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.0 | 0.2 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
| 0.0 | 0.2 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
| 0.0 | 0.4 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.0 | 0.5 | GO:0035586 | purinergic receptor activity(GO:0035586) |
| 0.0 | 0.1 | GO:0070538 | oleic acid binding(GO:0070538) |
| 0.0 | 0.1 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
| 0.0 | 0.2 | GO:1990446 | U1 snRNP binding(GO:1990446) |
| 0.0 | 0.3 | GO:0042923 | neuropeptide binding(GO:0042923) |
| 0.0 | 0.4 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
| 0.0 | 0.7 | GO:0015248 | sterol transporter activity(GO:0015248) |
| 0.0 | 0.1 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
| 0.0 | 0.1 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
| 0.0 | 0.1 | GO:0008066 | glutamate receptor activity(GO:0008066) |
| 0.0 | 0.0 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
| 0.0 | 0.2 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.0 | 0.2 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
| 0.0 | 0.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 0.0 | 0.4 | GO:0015631 | tubulin binding(GO:0015631) |
| 0.0 | 0.0 | GO:0004320 | oleoyl-[acyl-carrier-protein] hydrolase activity(GO:0004320) myristoyl-[acyl-carrier-protein] hydrolase activity(GO:0016295) palmitoyl-[acyl-carrier-protein] hydrolase activity(GO:0016296) acyl-[acyl-carrier-protein] hydrolase activity(GO:0016297) |
| 0.0 | 0.1 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.0 | 0.1 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
| 0.0 | 0.1 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
| 0.0 | 0.2 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.0 | 0.1 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
| 0.0 | 0.0 | GO:0005499 | vitamin D binding(GO:0005499) |
| 0.0 | 0.5 | GO:0008009 | chemokine activity(GO:0008009) |
| 0.0 | 0.3 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.0 | 0.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.0 | 0.0 | GO:1901338 | catecholamine binding(GO:1901338) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.5 | 33.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 1.0 | 56.0 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.9 | 25.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.9 | 33.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.8 | 10.6 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.8 | 30.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.8 | 35.0 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.8 | 32.7 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
| 0.7 | 60.1 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.7 | 3.5 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.7 | 41.2 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.5 | 2.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.5 | 17.5 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.5 | 22.4 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 0.5 | 24.4 | PID MYC PATHWAY | C-MYC pathway |
| 0.5 | 2.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.5 | 4.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.5 | 6.3 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.5 | 1.4 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.5 | 4.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.5 | 28.8 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.5 | 10.9 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.4 | 33.3 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.4 | 6.8 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.4 | 35.8 | PID E2F PATHWAY | E2F transcription factor network |
| 0.4 | 8.8 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.4 | 14.1 | PID ATM PATHWAY | ATM pathway |
| 0.4 | 1.2 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.4 | 2.6 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
| 0.4 | 1.5 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
| 0.4 | 4.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.4 | 3.9 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.3 | 3.8 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.3 | 2.0 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
| 0.3 | 12.7 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.3 | 2.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.3 | 3.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.3 | 3.0 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
| 0.3 | 12.3 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 0.3 | 15.4 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.3 | 11.8 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.3 | 11.3 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.3 | 8.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.3 | 2.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
| 0.3 | 9.9 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.3 | 0.3 | PID REELIN PATHWAY | Reelin signaling pathway |
| 0.3 | 14.1 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.3 | 7.6 | PID ATR PATHWAY | ATR signaling pathway |
| 0.3 | 3.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.2 | 3.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.2 | 3.8 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.2 | 4.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.2 | 4.4 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.2 | 0.8 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.2 | 2.2 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
| 0.2 | 1.9 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.2 | 8.5 | PID BMP PATHWAY | BMP receptor signaling |
| 0.2 | 0.4 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.2 | 8.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.2 | 4.6 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.2 | 9.5 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.2 | 6.7 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.2 | 2.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.2 | 10.4 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
| 0.2 | 0.3 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 0.2 | 5.8 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 0.2 | 11.1 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
| 0.2 | 6.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.2 | 5.3 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.1 | 4.6 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.1 | 3.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 0.1 | 1.8 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.1 | 0.5 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.1 | 5.3 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.1 | 7.6 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.1 | 0.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.1 | 0.4 | ST ADRENERGIC | Adrenergic Pathway |
| 0.1 | 3.7 | PID ERBB4 PATHWAY | ErbB4 signaling events |
| 0.1 | 2.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
| 0.1 | 0.6 | PID EPO PATHWAY | EPO signaling pathway |
| 0.1 | 0.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.1 | 2.5 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.1 | 4.0 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.1 | 0.3 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 0.1 | 2.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.0 | 0.7 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 0.0 | 0.1 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
| 0.0 | 0.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.0 | 0.6 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.0 | 0.6 | PID BARD1 PATHWAY | BARD1 signaling events |
| 0.0 | 0.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.0 | 0.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.0 | 0.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.0 | 0.3 | SIG CHEMOTAXIS | Genes related to chemotaxis |
| 0.0 | 0.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.0 | 0.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.0 | 0.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.4 | 2.9 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
| 1.2 | 34.7 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 1.2 | 14.0 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
| 1.2 | 53.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 1.1 | 19.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 1.1 | 30.7 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 1.1 | 3.2 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
| 1.1 | 21.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 1.0 | 9.2 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 1.0 | 11.9 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
| 1.0 | 37.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 1.0 | 26.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.9 | 16.8 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.9 | 9.2 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.9 | 20.0 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.9 | 20.9 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
| 0.7 | 4.3 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
| 0.7 | 27.6 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
| 0.7 | 3.4 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 0.7 | 38.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.7 | 28.8 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.6 | 1.3 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 0.6 | 6.9 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
| 0.6 | 11.1 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
| 0.6 | 30.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.6 | 6.0 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 0.6 | 4.7 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.6 | 2.3 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
| 0.6 | 27.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.6 | 13.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.5 | 18.6 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
| 0.5 | 9.4 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.5 | 1.0 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
| 0.5 | 9.3 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
| 0.5 | 17.8 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
| 0.5 | 7.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.5 | 4.3 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
| 0.5 | 7.4 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.5 | 3.7 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
| 0.5 | 26.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 0.4 | 8.4 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.4 | 10.0 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 0.4 | 9.7 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
| 0.4 | 8.0 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.4 | 13.0 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 0.4 | 10.5 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
| 0.4 | 10.8 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.4 | 3.7 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.4 | 1.2 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 0.4 | 7.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.4 | 2.4 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
| 0.4 | 10.8 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
| 0.4 | 3.2 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
| 0.4 | 8.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.4 | 3.4 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
| 0.4 | 29.6 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.4 | 5.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.4 | 5.8 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
| 0.4 | 4.7 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
| 0.3 | 16.0 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.3 | 7.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.3 | 10.4 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
| 0.3 | 7.0 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
| 0.3 | 8.0 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
| 0.3 | 80.3 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.3 | 5.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
| 0.3 | 2.5 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.3 | 0.6 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
| 0.3 | 0.9 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.3 | 3.9 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
| 0.3 | 10.4 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
| 0.3 | 4.0 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.3 | 2.0 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
| 0.3 | 2.5 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.3 | 0.8 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
| 0.3 | 3.7 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.3 | 2.6 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.3 | 0.5 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.3 | 4.5 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.2 | 0.5 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.2 | 0.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.2 | 1.9 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.2 | 17.4 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
| 0.2 | 6.9 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.2 | 1.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.2 | 6.3 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
| 0.2 | 3.9 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
| 0.2 | 0.7 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
| 0.2 | 2.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
| 0.2 | 23.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.2 | 3.2 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
| 0.2 | 5.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.2 | 3.5 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.2 | 1.8 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
| 0.2 | 6.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.2 | 2.1 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.2 | 14.0 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
| 0.2 | 4.3 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 0.2 | 4.5 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.2 | 2.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.2 | 2.0 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.2 | 7.9 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.2 | 4.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.2 | 12.8 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
| 0.2 | 1.9 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
| 0.1 | 3.3 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
| 0.1 | 0.4 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
| 0.1 | 2.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.1 | 2.2 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
| 0.1 | 2.3 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
| 0.1 | 2.1 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
| 0.1 | 2.5 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.1 | 1.7 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 0.1 | 2.1 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
| 0.1 | 0.7 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.1 | 2.5 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.1 | 9.8 | REACTOME METABOLISM OF MRNA | Genes involved in Metabolism of mRNA |
| 0.1 | 6.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.1 | 2.4 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.1 | 1.0 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 0.1 | 1.2 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.1 | 1.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.1 | 2.7 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.1 | 1.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.1 | 1.1 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
| 0.1 | 0.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.1 | 3.3 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.1 | 0.9 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.1 | 0.7 | REACTOME OPSINS | Genes involved in Opsins |
| 0.1 | 0.9 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
| 0.1 | 1.0 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.1 | 1.8 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.1 | 0.6 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.1 | 0.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.1 | 0.8 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.1 | 1.5 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.1 | 0.6 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 0.1 | 0.4 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
| 0.1 | 0.9 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.0 | 0.3 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
| 0.0 | 0.3 | REACTOME HIV LIFE CYCLE | Genes involved in HIV Life Cycle |
| 0.0 | 0.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.0 | 0.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.0 | 0.6 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
| 0.0 | 0.6 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.0 | 0.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.0 | 4.6 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.0 | 0.3 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.0 | 0.2 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
| 0.0 | 0.5 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.0 | 0.2 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
| 0.0 | 0.4 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.0 | 0.2 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 0.0 | 0.3 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
| 0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
| 0.0 | 0.2 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
| 0.0 | 0.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.0 | 0.2 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |